Annals of the Rheumatic Diseases A journal of clinical and connective tissue research

This journal was founded by the Empire Council, now the and Rheumatism Councilfor Research in Great Britain and the Commonwealth, and is also supported by the British Society for Rheumatology Advice to contributors Communications This journal exists to publish work on all Illustrations These should be marked on the back with the aspects of rheumatology and disorders of connective author's name, numbered, and the top edge indicated. tissue. Laboratory as well as clinical studies are welcome. Separate illustrations should be separately numbered. In addition brief communications, for example reports of Arrows or other symbols must be inserted by the author on single cases, will be printed if of exceptional interest. the illustration (not on superimposed paper). Radiographs Papers, which will be accepted on the understanding that should be.submitted as prints suitable for reproduction. they have not been and will not be published elsewhere Line drawings must have lettering large enough to be clear and are subject to editorial revision, should be addressed when reduced on the page. Legends to illustrations should to The Editor, Professor H. L. F. Currey, London be typed in double spacing on a separate sheet and those Hospital Medical College, London El 2AD. Each author for photomicrographs should include stain and magnifica- must sign the covering letter as evidence of consent to tion. publication. Two copies should be supplied, one a typed top copy. Tables Each table should be on a separate sheet, have a Authors requiring acknowledgement of papers submitted heading, and contain no vertical rules. should enclose a stamped addressed postcard or, if overseas, an international reply paid coupon. Proofs Contributors will receive ONE proof, and should Articles must be typewritten on one side of the paper read it carefully for printers' errors. Alterations to the only, in double spacing with ample margins. Only recog- original text should be kept to a minimum and may be nised abbreviations should be used. charged to the author.

SI units If the work is not reported in SI units, the Reprints 25 reprints will be supplied free of charge. equivalent in SI units must be given in parentheses after Additional reprints may be ordered from the Publishing the units used. Manager when the proofs are returned. Notice to subscribers Key words Three to 10 key words or short phrases should The annual subscription rates are available on request to be provided below the summary. They are to assist the Subscriptions Manager of Annals of the Rheumatic indexers in cross-indexing the article, and they therefore Diseases, BMA House, Tavistock Square, London WC1H should not include words already in the title. When 9JR. Orders can also be placed locally through any leading possible the terms used should be from the list of medical subscription agent or bookseller. (For the convenience of subject headings in the Index Medicus (MESH). readers in the USA subscription orders, with or without payment, can be sent to: BRITISH MEDICAL JOUR- References In accordance with the Vancouver agreement NAL, Box 560B, Kennebunkport, Maine 04046, USA. All references, which must be typed double spaced, are cited inquiries, however, must be addressed to the publisher in by the numerical system. London.) A paper (or book) cited in the text is referred to there by All inquiries regarding air mail rates and single copies a superscript number. In the list of references the papers already published should also be addressed to the pub- (or books) appear in the numerical order in which they are lisher in London. cited in the text, not in alphabetical order by author's names. For convenience in preparing the typescript the Notice to advertisers reference number may be typed between parentheses on Applications for advertisement space and for rates should the line, not superscript. The titles of journals are be addressed to the Advertisement Manager, Annals ofthe abbreviated in accordance with the style of Index Medicus. Rheumatic Diseases, B.M.A. House, Tavistock Square, In the typescript they should either be abbreviated in that London WC1H 9JR. style or given in full. Three examples follow: COPYRIGHT (© 1984 by the Green A B, Brown C D, Grey E F. A new method of Annals of the Rheumatic Diseases measuring the glucose. Ann Rheum Dis 1980; 64: This publication is copyright under the Berne Convention 27-9. and the International Copyright Convention. All rights 2 Green A B, Brown C D. Textbook of Medicine. reserved. Apart from any relaxations permitted under London: Silver Books, 1980. national copyright laws, no part of this publication may be 3 Grey E F. Diseases of the pancreas. In: Green A B, reproduced, stored in a retrieval system, or transmitted in Brown C D, eds. Textbook ofMedicine. London: Silver any form or by any means without the prior permission of Books, 1980: 349-62. the copyright owners. Permission is not, however, required to copy abstracts of papers or of articles on condition that a References will not be checked in the editorial office. full reference to the source is shown. Multiple copying of Responsibility for their accuracy and completeness lies the contents of the publication without permission is with the author. always illegal. December 1984 Volume 43 No 6 Annals of the Rheumatic Diseases

A journal of clinical rheumatology and connective tissue research

EDITOR H. L. F. Currey

ASSOCIATE EDITORS C. G. Barnes V. Wright

EDITORIAL COMMITTEE B. M. Ansell E. G. L. Bywaters A. M. Denman A. St. J. Dixon D. L. Gardner E. B. D. Hamilton T. E. Hardingham E. J. Holborow G. R. V. Hughes P. M. Johnson P. J. Maddison R. N. Maini A. G. Mowat R. G. G. Russell K. W. Walton J. B. Weiss P. H. N. Wood D. E. Woolley Editor British Medical Journal

Appointed by the British Medical Association

TECHNICAL EDITOR T. D. V. Swinscow

Thisjournal publishes papers on all aspects ofrheumatology and disorders of connective tissue. Laboratory as well as clinical studies are welcome. In addition briefcommunications, for example reports ofsingle cases, will be printed ifofexceptional interest.

PUBLISHED SIX TIMES A YEAR

British Medical Association Tavistock Square London WC1H 9JR Annals of the Rheumatic Diseases, 1984, 43, 858 Notes Rheumatology and rehabilitation Variation in NSAID response The Council of the Section of Rheumatology and Rehabili- tation of the Royal Society of Medicine invites short A satellite meeting to the XVI International Congress of clinical and scientific papers on any subject in rheumatol- Rheumatology (Sydney, Australia, 19-25 May 1985) will ogy and rehabilitation for a meeting to be held on 13 be held on 17-18 May 1985 to discuss 'NSAID in rheumatic February 1985. 3.00 to 6.00 pm. Authors need not disease: basis for intersubject variability in response.' The necessarily belong to the RSM. Abstracts should be meeting will be at Leura, Blue Mountains, New South submitted on one side of A4 paper no later than 17 Wales. Details from R. 0. Day, MD, Department of December 1984. Details from Dr W. D. Hayley, Honorary Clinical Pharmacology, St Vincent's Hospital, Darling- Secretary, Section of Rheumatology and Rehabilitation, hurst, Sydney 2010, Australia. Royal Society of Medicine, 1 Wimpole Street, London WlM 8AE. Rheumatology congress The IX Panamerican Congress of Rheumatology will be held on 17-22 November 1986, at Buenos Aires, Argenti- na, sponsored by the Argentine Society of Rheumatology. Details from Dr. 0. Hubscher, Secretary General, IX Conference on Behqet's disease PANLAR Congress, Austria 2469-70 'A', Buenos Aires 1425, Argentina. A multidisciplinary International Conference on Behcet's disease will be held under the auspices of the Royal Society of Medicine in London on 5-6 September 1985. It is hoped EULAR symposium that there will be international participation from special- ists of many disciplines to review recent advances in the A symposium will be held on 'Aspects of experimental and understanding of the aetiology, pathogenesis, clinical clinical drug treatment for rheumatic diseases' in Vienna manifestations, and treatment of this intractable multi- on 9-12 October 1985. Details from Professor Dr. G. system disease. Details from Miss M Mitchell, Royal Kolarz, c/o Medizinische Akademie, Alser Strasse 4, Society of Medicine, 1 Wimpole Street, London Wl. A-1090 Vienna, Austria. Annals of the Rheumatic Diseases, 43, 1984

INDEX TO VOLUME 43, 1984

P = Proceedings of the Heberden Society

AALBERSE RC see HACK C E et al Amyloid AARONS L see GRENNAN D M and AARONS L A protein, serum concentration, in progressive ABADi I see RODRfGUEZ M A et al systemic sclerosis (scleroderma) 586 ADAM M and DEYL Z Degenerated annulus fibrosus of in intervertebral discs, age distribution: correspon- the intervertebral disc contains collagen type II 258: dence 663 correction 540 disease, dimethylsulphoxide (DMSO) and colchicine Adjuvant arthritis, rat, gold exacerbating; correspon- therapy 421 dence 350 Amyloidosis and systemic lupus erythematosus: case Adjuvant report 649 disease, possible, scleroderma, primary biliary ANDERSEN 0 ROMBERG- see RoMBERG-ANDERSEN 0 cirrhosis, and Sjorgren's syndrome after cosmetic ANDERSON J A D see GRAHAME R et al breast augmentation with silicone injection: case ANDERSON N E and ALI M R The lupus anticoagulant, report 520 pulmonary thromboembolism, and fetal pulmonary induced arthritis, lymphoid abnormalities, rats. I. hypertension: case report 760 Mitogen responsiveness and lymphokine synthesis, Angioimmunoblastic lymphadenopathy, and arthritis: 847 correspondence 536 , influence of rat strain and arthritogen Angioneurotic oedema, localised form, rheumatoid on actions of gold drugs 111 P synovitis 109 P Adolescents, joint mobility, quantitative measurements, 288 absence of impaired lymphocyte transformation to ADOLPHE M see JAFFRAY P et al Klebsiella spp. 590 AFOKE N Y P, BYERS P D and HurrON W C The and arthritis of the middle ear: case report 658 incongruous hip joint: a loading study 295 and employment 604 AHERN M see SYMMONS D P M et al HLA B27, and polymorphonuclear cell motility 279 AHERN M J, HALL N D, CASE K and MADDISON P J D- increased number of IgG-containing cells in rectal penicillamine withdrawal in lamina propria 172 213 klebsiella carriage modification by diet, correlation of see also KLOUDA P T et al klebsiella carriage with disease activity 196 AKO1LU T, TUNCER I, ERKEN E, GURgAY A, OZER F L low back pain, sacroiliac tests, 2 studies 192 and OZCAN K Parasitic arthritis induced by North India, clinical and immunogenetic study 381 Strongyloides stercoralis: case report 523 radiological changes, men and women 570 ALBISER G, NETrER P, FAURE G, HORN P, DELAGOurrE two-dimensional gel analysis in demonstration of non- J P and GAUCHER A Human articular cartilage and structural alteration of HLA-B27 polypeptides 177 fibrocartilage: A study with high-angle x-ray dif- and yersinia arthritis, immunoglobulins (M, G, and fraction 802 A) 186 ALEGRIA J GARCIA see GARCIA-ALEGRIA J Annulus fibrosus, degenerated, of intervertebral disc, ALI M R see ANDERSON N E and ALI M R contains collagen type II, 258: correction 540 ALLAL J see THOMAS Ph et al ANSELL B M see BURGOS-VARGOS R et al ALLISON M C and GALLAGHER P J Temporal artery DE VERE-TYNDALL A et al biopsy and corticosteroid treatment 416 HALL P J et al ALTMAN R D, TENENBAUM J, LATTA L, RISKIN W, Antibodies, anti-idiotypic, use to demonstrate rheumatoid BLANCO L N and HOWELL D S Biomechanical and factor producing bone marrow cells in essential biochemical properties of dog cartilage in experi- mixed cryoglobulinaemia: case report 651 mentally induced 83 detection by new solid phase radioimmunoassay, strik- AMBANELLI U see FERRACCIOLI G F et al ing association with thrombosis 122 P AMLOT P L see SYMMONS D P M et al Antiocardiolipin antibodies, occurrence in Beh;et's AMOS N see Woo P et al syndrome 746 859 860 Index Antihypertensive therapy, systemic sclerosis (sclero- AYED K see HAMZA M et al derma), controlled trial 407 Antimitochondrial antibodies, and polymyalgia B lymphocytes, synovial fluid, spontaneous and induced rheumatica 264 immunoglobulin secretion, rheumatoid arthritis 140 Antirheumatoid drugs, practical results of treatment 121 BACON P A see FARR M et al p Scorr D G I et al Apatite-associated destructive arthritis 120 P Sco-r D L et al , symmetrical, and shoulder-hand syndrome, in SYMMONS D P M et al tubo-ovarian carcinoma 391 BACON T see DE VERE-TYNDALL A et al Arthritides, septic and non-septic, synovial fluid lactate Bacterial phagocytosis, enhanced, peripheral blood levels 742 monocytes, rheumatoid arthritis 435 Arthritis BADLEY E M, WAGSTAFF S and WOOD P H N Measures and angioimmunoblastic lymphadenopathy: correspon- of functional ability (disability) in arthritis in relation dence 536 to impairment of range of joint movement 563 cryptococcal, and cellulitis: case report 508 BALL J see HILTON R C and BALL J disability in, measures 563 BALOW J E see KLIPPEL J H et al experimental, treatment with "7Lu in chelator BANKS E see FITZCHARLES M et al liposomes, rabbit 111 P FITZCHARLES M A et al gonococcal, bacterial confirmation: correspondence BANYAI A see LUKACS K et al 537 BARBER K E, Gow P J and MAYO K M A family with middle ear, in ankylosing spondylitis: case report 658 multiple muscoloskeletal abnormalities 275 non-gouty, in sickle-cell disease, 37 consecutive cases BARD D R, KNIGHT C G and PAGE-THOMAs D P 599 Treatment of a rabbit experimental arthritis with ARTHRITIS AND RHEUMATISM COUNCIL MULTICENTRE '77Lu in chelator liposomes 111 P RADIOSYNOVIORTHESIS TRIAL GROUP Intraarticular BARDIN T, SCHUMACHER H R, LANSAMAN J, ROTHFUSS radioactive yttrium and triamcinolone hexacetonide: S and DRYLL A Transmission electron microscopic an inconclusive trial 620 identification of silicon-containing particles in ARMAS P see RODRfGUEZ M A et al synovial fluid: potential confusion with calcium pyrophosphate dihydrate and apatite crystals 624 acute sterile, pyogenic osteomyelitis presenting as 607 BARNES C G see DAVIES P G et al bilharzial 806 THOMPSON P W et al erosive and nonerosive, synovial protease/inhibitor BARTH W F see BUNNING R D and BARTH W F ratios 50 BASSAN H M see POTASMAN I and BASSAN H M Articular cartilage BASSIOUNI M and KAMEL M Bilharzial arthropathy 806 cultured, oxygen free-radicals mediate an inhibition of BATCHELOR J R see GRIFFIN A J et al proteoglycan synthesis 462 BATES E J, LoWTHER D A and HANDLEY C J Oxygen differential responses to retinol 833 free-radicals mediate an inhibition of proteoglycan and fibrocartilage, high-angle x-ray diffraction 802 synthesis in cultured articular cartilage 462 Articular chondrocytes, cultured rabbit, effects of D- BATSTONE G F see HELLIWELL M et al penicillamine on growth and cell cycle kinetics 333 BECQ-GIRAUDON B see THOMAS PH et al in monolayer culture, normal human, identification of BEER M see Ng K C et al ectoenzyme, nucleoside triphosphate pyrophospho- REVELL P A et al hydrolase 107 P Behqet's disease ASHERSON R A see HULL R G et al age and sex incidence, effect on prevalence and Aspiration of retrocalcaneal bursa 308 severity 783 ATKINSON S J see HEATH J K et al anticardiolipin antibodies 746 Auranofin, gold nephropathy obscured by tolmetin pathergy test, Britain 70 pseudoproteinuria: case report 511 among Turkish and British patients, comparative Aurothiomalate, sodium, free thiomalate in plasma and study 74 urine 66 synovial fluid complement levels: correspondence 767 AUSTIN H A see KLIPPEL J H et al BELCH J J F, LOWE G D 0, FORBES C D, CAPELL H and Autoantibodies STURROCK R D Increased 6-keto-PGF1 a levels and frequency to nRNP, Sm, Ro(SSA), and La(SSB), in decreased red cell deformability in patients with connective tissue diseases 122 P systemic sclerosis 117 P sicca syndrome (primary Sjogren's syndrome) 243 McARDLE B, MADHOK R, McLAUGHLIN K, CAPELL H A, FORBES C D and STURROCK R D Decreased cellular protein and RNA antigens 123 P plasma fibrinolysis in patients with rheumatoid rheumatic, Greek patients, antibodies to cellular arthritis 774 antigens, anti-Ro(SSA) antibody a possible marker of BELL D A see LERICHE N G H and BELL D A penicillamine-D intolerance 285 BEN AYED H see HAMZA M et al AYAD S see EVANS H B et al BENFIELD G F A see WRIGHT A et al AYED H BEN see BEN AYED H BENSON M D see SCHEINBERG M A et al Index 861

BERNSTEIN R M, BUNN C C, HUGHES G R V, resorption by copper, inhibition of prostaglandin action FRANCOEUR A M and MATHEWS M B Cellular 841 protein and RNA antigens in autoimmune disease possible role of osteoblasts 105 P 123 P BONTOUX D see THOMAS PH et al MACKWORTH-YOUNG C G, SAVERYMUTU S H, GuPTA S, BONVOISIN B, CORDIER G, REVILLARD J P, LEJEUNE E ENGLAND J P S and HUGHES G R V Yersinia and BOUVIER M Increased DNA and/or RNA arthritis: demonstration of occult enteritis by content of synovial fluid cells in rheumatoid arthritis: "'indium leucocyte scanning: case report 493 a flow-cytometry study 222 BERTOUCH J V see GALE R et al BOOK REVIEWS BESSAC B see HURST N P et al ANSELL B M and SIMKIN P A editors The heart and BEVERLEY P C L see ISENBERG D A et al rheumatic disease, vol. 2. 397 BHARGAVA S see PRAKASH S et al BEIGHTON GRAHAME R and BIRD H BIGNOLD L P see VERNON-ROBERTs B et al P, Hyper- Bilharzial arthropathy 806 mobility of joints 1983 191 Biliary cirrhosis, primary, scleroderma, and Sjogren's BULLOUGH P G and VIGORITA V J Atlas of ortho- syndrome, after cosmetic breast augmentation with paedic pathology with clinical and radiological silicone injection, possible human adjuvant disease: correlations 1984 766 case report 520 CALLEN J P editor Clinics in rheumatic diseases, BINDER A see DE SILVA M et al vol 8, no 2. Cutaneous lesions in the connective BINDER A I, BULGEN D Y, HAZLEMAN B L and ROBERTS tissue disorders 1982 49 S Frozen shoulder: a long-term prospective study CAPELL H A, DAYMOND T J and DICK W C 361 Rheumatic disease 1983 135 TUDOR J and WRAIGHT P Frozen shoulder: an arthro- CASSIDY J T Textbook of pediatric rheumatology graphic and radionuclear scan assessment 365 1982 377 see also BULGEN D Y et al CLAUSTRE J and SIMON L editors Le pied en Biotechnology, international symposium, Rome, April pratique rheumatologique: pathologie articularie 1985, announcement 768 1983 59 BIRD H A see SiTrON N G et al Council of Biology Editors CBE style manual, BJELLE A see HALLGREN R et al 5th edn 1983 33 BLACK C M see HAWKINS S et al DICK W C and MOLL J M H editors Recent BLAKE D see WINYARD P et al advances in rheumatology No. 3 1983 156 BLAKE D R, BRAILSFORD S, WINYARD P and LUNEC J A DIXON A ST J and GRABER J Local injection role for extracellular ferritin in 107 P therapy in rheumatic diseases 1983 145 see also ROWLEY D et al FORRESTER D and BROWN J C editors Radiological ScoTr D G I et al investigations in rheumatology. Clinics in BLANCO L N see ALTMAN RD et al rheumatic diseases. Vol. 9, No. 2. 1983 623 BLANN A see Scorr D G I et al GHADIALLY F N Fine structure of synovial joints WINYARD P et al 1983 390 GRIFFITHS I D and PLArr P Multiple choice BLOWER P W and GRIFFIN A J Clinical sacroiliac tests questions in rheumatology 1984 550 in causes ankylosing spondylitis and other of low HUGHES J Footwear and footcare for adults 1983 back pain-2 studies 192 127 BOEY M L see HARRIS E N et al Footwear and footcare for disabled children 1983 BOGDUK N, MAJOR G A C and CARTER J Lateral 127 subluxation of the atlas in rheumatoid arthritis: a case HuSKISSON E C editor Clinical pharmacology and report and post-mortem study: case report 341 therapeutic series. Vol. 3. Antirheumatic drugs BOGHOSSIAN S H, ISENBERG D A, WRIGHT G, SNAITH M 1983 263 L and SEGAL A W Effect of high-dose methyl- JAYSON M I V and MILLION R editors Locomotor prednisolone therapy on phagocyte function in disability in general practice. Oxford General systemic lupus eruthematosus 541 Practice Series 5 1983 23 BOHM U see MERtTEY K et al JEFFERY M S and DICK W C Clinics in rheumatic Bone diseases 1983 150 cells, trabecular, cyclic AMP modulated by heparin 628 KEMP J and WINKLER J T Problems afoot: need and disease, assessment and treatment: conference report efficiency in footcare 1983 127 660 MCCULLOCH J A and McNAB I Sciatica and formation, new and osteosclerosis, young and late chymopapain 1983 659 onset rheumatoid arthritis, according to rheumatoid MOLL J M H Management of rheumatic disorders factor seropositivity: correspondence 661 1983 585 joint, and connective tissue pathology meeting, RICKETF J C and RADIN E L editors Chondromalacia Manchester, September 1984, announcement 352 of the patella 1983 294 and joint symptoms, Paget's disease 769 SCHUR P H editor The clinical management of mass, in nodal primary generalised osteoarthrosis 240 systemic lupus erythematosus 1983 385 862 Index Symposium/Workshop, London Hospital, March juvenile chronic arthritis previously tissue typed for 1983. Advances in assessing rheumatoid HLA-A and B loci 119 P arthritis. British Journal of Rheumatology BURMAN S J see HALL P J et al Supplement 1983 7 Bursitis WRIGHT V editor Bone and joint disease in the calcifying supracoracoid, causing chronic shoulder elderly 1983 326 pain: case report 758 BOUCHER B J see Ng K C et al olecranon, traumatic corticosteroid injection, long-term REVELL P A et al follow-up 44 BOURNE J T see CARTER S D et al supracoracoid, calcifying, causing chronic shoulder BOUVIER M see BONVOISIN B et al pain: case report 758 BRADFIELD J see DIEPPE P A et al BUTLER B D see HILLS B A and BUTLER B D BRADLEY B A see KLOUDA P T et al BUTLER R C, THOMAS S M, THOMPSON J M and KEAT BRADLEY J see GALE R et al A C S Anaplastic myeloma in systemic lupus erythe- BRAILSFORD S see BLAKE D R et al matosus: case report 653 ScoTr D G I et al see also STODELL M A et al WINYARD P et al BYERS P D see AFOKE N Y P et al BRANDWEIN S R, MEDSGER T A, SKINNER M, SIPE J D, RODNAN G P and COHEN A S Serum amyloid A protein concentration in progressive systemic C4 deficiency, selective, systemic lupus erythematosus, sclerosis (scleroderma) 586 and Whipple's disease: case report 91: BRAVO J R see RODRfGUEZ M A et al correspondence 535 Breast augmentation, cosmetic, with silitone injection, Caeruloplasmin inflammatory joint disease 108 P scleroderma, primary biliary cirrhosis, and Sjogren's Calcium phosphate crystals syndrome after, possible human adjuvant disease: arthropathy, histopathological and ultrastructural case report 520 studies of synovium in Milwaukee shoulder BRENNAND D see MADDISON P J et al syndrome 734 BRERETON J D see O'CONNON P et al clearance from facsimile synovium 487 BREWER E J see GIANNINI E H et al deposition disease, and haemochromatosis, arthro- BREWERTON D A see STODELL M A et al pathy of: correspondence 536 BRIGGS D see HALL P J et al CALIN A Osteosclerosis and new bone formation in BROMLEY M, FISHER W D and WOOLLEY D E Mast cells young onset and late onset rheumatoid arthritis at sites of cartilage erosion in the rheumatoid according to seropositivity: joint 76 correspondence 661 Bronchiolitis obliterans, fatal, associated with chryso- CALIN H J, FIELD E, TANAY A, STROBER S, HOPPE R therapy: correspondence 351 and KAPLAN H Double-blind controlled study of BROOKS P M see THOMAS D et al total lymphoid irradiation (TLI) in rheumatoid VERNON-ROBERTS B et al arthritis (RA) 121 P BROUGHAM P A, MCGILL P E and TULLOCH J Immune see also LowTHIAN P et al deposits at the dermoepidermal junction in patients CALIN H J see CALIN A et al with rheumatoid arthritis: correspondence 537 CAMPION G see GHARAVI A E et al BROWN G and EMERY P et al Cancer morbidity, in rheumatoid arthritis 128 BROWN J see FRIES J F et al CANOSO J J and WOHLGETHAN J R C4 deficiency, SLE, BROWN K A see GODDARD D H et al and Whipple's disease: correspondence 535 BROWN R see GRAHAME R et al NEWBERG A H and GOLDSMITH M R Aspiration of PRIOR P et al the retrocalcaneal bursa 308 Brown's syndrome, transient, in juvenile chronic see also WEINSTEIN P S et al arthritis: case report 764 CAPELL H see BELCH J J F et al Brucellosis and rheumatic syndromes, Saudi Arabia 810 MADHOK R et al BUCKLAND-WRIGHT J C Microfocal radiographic CAPELL H A, PULLAR T, MADHOK R and LEWIS examination of erosions in the wrist and hand of D Absence of placebo response during second-line patients with rheumatoid arthritis 160 therapy: an obstacle to outcome measurement in RA BUDDECKE E see HERWIG J et al 114 P BULGEN D Y, BINDER A I, HAZLEMAN B L, DUTTON J see also BELCH J J F et al and ROBERTS S Frozen shoulder: prospective PULLAR T et al clinical study with an evaluation of three treatment CARLSON R P see GILMAN S C et al regimens 353 Carpal tunnel syndrome and subsequent rheumatoid see also BINDER A I et al arthritis in the 'fibrositis' syndrome 232 BUNN C C see BERNSTEIN R M et al CARTER J see BOGDUK N et al BUNNING R D and BARTH W F Cryptococcal arthritis CARTER S D, BOURNE J T, ELSON C J, HUT-rON C W, and cellulitis: case report 508 CZUDEK R and DIEPPE P A Mononuclear BURGOS-VARGOS R, HALL M A and ANSELL B M phagocytes in rheumatoid arthritis: Fc-receptor Sacroiliac changes at the 10-year follow-up of expression by peripheral blood monocytes 424 Index 863 Cartilage COHEN R D see Ng K C et al biomechanical and biochemical properties, in experi- REVELL P A et al mentally induced osteoarthritis, dog 83 Colchicine therapy and dimethylsulphoxide (DMSO), degradation in vivo, effects of local administration of amyloid disease 421 hydrocortisone 418, 106 P Collagen types erosion sites, rheumatoid joint, mast cells 76 fibronectin and proteoglycans, localisation in cartilage localisation of collagen types, fibronectin and proteo- 107 P glycans 107 P II, contained in degenerated annulus fibrosus of inter- CASE K see AHERN M J et al vertebral disc 258: correction 540 CASWELL A M and RUSSELL R G G Identification of the COLLINS A J, NOTARIANNI L J, LLEWELLYN D H, ectoenzyme, nucleoside triphosphate pyrophospho- JEFFERIES T M and FERRIE J E Pharmacokinetics of hydrolase, in normal human articular chondrocytes in D-penicillamine in man 112 P monolayer culture 107 P RING E F J and SEED M P Some observations on the CATS A see STEVEN M M et al pharmacology of 'deep-heat', a topical rubifacient CAVALIERI F see FERRACCIOLI G F et al 411 COLTON C L see GRIFFITHS H T et al CAWLEY M I D see COOPER C and CAWLEY M I D Congress of the European Society of Ophthalmology, SAlTAR M A et al seventh, May 1984, Helsinki, announcement 123 Cellular protein and RNA antigens, in autoimmune Congress of Physical Medicine and Rehabilitation, 9th, disease 123 P May 1984, Jerusalem, announcement 123 Cellulitis, and cryptococcal arthritis: case report 508 Connective tissue Centromere antigen reactive, in CREST syndrome 819 diseases, frequency of autoantibodies to nRNP, Sm, CERESIA G see MAGARb et al Ro(SSA), and La(SSB), using an ELISA technique CEULAER K DE see DE CEULAER K 122 P CHADWICK V S see PARKE A L et al microvascular filtration, abnormalities 109 P CHAIAMNUAY P, JOHNSTON C, MAIER J and RUSSELL turnover, modulation by partially purified human A S Technique-related variation in results of FANA mononuclear cell factor/interleukin-1 106 P tests 755 COOKE E M see SHINEBAUM R et al CHAMBERLAIN M A see YAZICI H et al COOMBES E J see HELLIWELL M et al CHAPUT DE SAINTONGE M see KIRWAN J R et al COOPER C and CAWLEY M I D Rheumatoid arthritis Cheiroarthropathy (joint mobility), limitation in adult and malignant histiocytosis of the intestine: noninsulin-dependent diabetes 251 correspondence 766 Chloroquine see also Woo P et al and dapsone, rheumatoid arthritis treatment, 6-month Copper, and bone resorption, inhibition of prostaglandin comparative study 200 action 841 its effect on leucocyte auto- and heterophagocytosis 205 CORBIN S see KLOUDA P T et al therapy, presence of abnormal lysosomes in lympho- CORDIER G see BONVOISIN B et al cytes and neutrophils during, quantitative ultra- CORRESPONDENCE structural study 710 Age distribution of amyloid in the intervertebral CHOY D see DE JAGER J P et al discs 663 Chrysotherapy Arthritis and angioimmunoblastic lymphadenopathy and fatal bronchiolitis obliterans: correspondence 351 536 and thrombocytopenia 113 P Arthropathy of calcium pyrophosphate deposition Circadian variation, in biochemical assessments used to disease and of haemochromatosis 536 monitor rheumatoid arthritis 444 Bacterial confirmation of gonococcal arthritis 537 Circulating immune complexes, isolated by affinity C4 deficiency, SLE, and Whipple's disease 535 chromatography from sera, rheumatoid arthritis, Fatal bronchiolitis obliterans, associated with analysis 116 P chrysotherapy 351 CLAGUE R see DYER P et al Gold exacerbates adjuvant arthritis, in the rat 350 CLAGUE R B see KLIMIUK P S et al History of rheumatic or glandular 124 CLARKE G see LEADER M et al HLA types and palindromic rheumatism 538 CLARRIS B J, FRASER J R E, MUIRDEN K D, MALCOLM Immune deposits at the dermoepidermal junction in L P, HOLMES M W A and ROGERS K Stimulation of patients with rheumatoid arthritis 537 glycosaminoglycan production and lysosomal activity Osteosclerosis and new bone formation in young of human synovial cells in culture by low environ- onset and late onset rheumatoid arthritis according mental pH 313 to rheumatoid factor seropositivity 661 CLEARY E G see VERNON-ROBERTS B et al Rheumatoid arthritis and malignant histiocytosis of CLELAND L G, VERNON-ROBERTS B and SMITH K Fibre the intestine 766 glass induced synovitis: case report 530 Rheumatoid arthritis and type 1 diabetes mellitus CLEMENTS P J see FURST D E et al 351 Coeliac disease, and rheumatoid arthritis 378 Salicylate-NSAID interactions 351 COHEN A S see BRANDWEIN S R et al 'Seronegative spondarthritis' 662 864 Index

Spontaneous rupture of the spleen in rheumatoid DAVIS P, JOHNSTON C, MILLER C and WONG K The arthritis 539 effect of gold compounds on the respiratory burst of Synovial fluid complement levels in Behqet's disease phagocytic cells 112 P 767 DAVIES P G, FORDHAM J N, KIRWAN J R, BARNES C G Tachyarrhythmia in yersinia arthritis 535 and DINNING W J The pathergy test and Behqet's Unusual case of dermatomyositis 662 syndrome in Britain 70 Vertebral rim lesions in dorsolumbar spine 662 DE CEULAER K, FORBES M, ROPER D and SERJEANT Corticosteroid G R Non-gouty arthritis in sickle cell disease: report injection, traumatic olecranon bursitis, long-term of 37 consecutive cases 599 follow-up 44 DE JAGER J P, CHOY D and FLEMING A Salivary local, effects on cartilage degradation in vivo 106 P scanning in rheumatoid arthritis with sicca syndrome Corticosteroid therapy, prolonged low-dose and osteo- 610 porosis in rheumatoid arthritis 24 and FLEMING A Shoulder joint rupture and pseudo- treatment, temporal artery biopsy 416 thrombosis in rheumatoid arthritis: case report 503 COULTON B L see ScoTr D L et al DE JONGH B M, VAN ROMUNDE L K J, VALKENBURG CORVALAN J F see HALL N D et al H A, DE LANGE G G and VAN ROOD J J Epidemio- CRESPO M see PENA J M et al logical study of HLA and GM in rheumatoid arthritis Crest syndrome and related symptoms in an open Dutch population centromere antigen reactive with sera 819 613 and progressive systemic sclerosis, clinical and sero- DE LANGE G G see DE JONGH B M et al logical comparison 794 DE SAINTONGE D M CHAPUT DE see CHAPUT DE CRISP A J, ROELKE M S, GOLDRING S R and KRANE SAINTONGE D M S M Heparin modulates intracellular cyclic AMP in DE SILVA M, BINDER A and HAZLEMAN B L The timing human trabecular bone cells and adherent of prednisolone dosage and its effect on morning stiff- rheumatoid synovial cells 628 ness in rheumatoid arthritis 790 Heparin modulates the response of cultured DE VERE-TYNDALL A, BACON T, PARRY R, TYRRELL human trabecular bone cells to hormones 105 P D A J, DENMAN A M and ANSELL B M Infection and CROOK P R see FOWLER P D et al interferon production in systemic juvenile chronic Cryoglobulins, characteristics, rheumatoid arthritis and arthritis: a prospective study 1 systemic lupus erythematosus, and their complement DECKER J L see KLIPPEL J H et al binding properties 451 'Deep-heat', topical rubifacient, observations on pharma- Cryoglobulinaemia cology 411 essential mixed, use of anti-idiotypic antibodies to Degeneration, human knee joint menisci, chemical demonstrate rheumatoid factor producing bone changes in various stages 635 marrow cells: case report 651 DELAGOUTTE J P see ALBISER G et al long-term, preceding systemic lupus erythematosus: DENMAN A M see DE VERE-TYNDALL A et al case report 339 HULL R G et al Cryptococcal arthritis and cellulitis: case report 508 DENT R see FITZCHARLES M et al CURREY H L F see HASKARD D 0 and CURREY H L F DER KORST J K VAN see VAN DER KORST J K KIRWAN J R et al Dermatomyositis, unusual case: correspondence 662 KIRWAN J R and CURREY H L F Dermoepidermal junction, in rheumatoid arthritis, Ng K C et al immune deposits: correspondence 537 PEASE C T et al DEYL Z see ADAM M and DEYL Z REVELL P A et al Diabetes mellitus CURWEN M see GRAHAME R et al adult noninsulin-dependent limitation of joint mobility Cyclic AMP, intracellular, modulated by heparin, in (cheiroarthropathy) 251 human trabecular bone cells and adherent type 1, and rheumatoid arthritis: correspondence 351 rheumatoid synovial cells 628 DICK H see MADHOK R et al CZUDEK R see CARTER S D et al DICKSON R see FROEBEL K et al DIEPPE P A, BRADFIELD J, DOHERTY M, HUIrON C, MACFARLANE D G and WA-rr I Apatite-associated destructive arthritis 120 P see also CARTER S D et al DALE E see GRAHAME R et al DIJKMAN J H see STEVEN M M et al DANIELS J F see GILMAN S C et al Dimethylsulphoxide (DMSO) and colchicine therapy, Dapsone amyloid disease 421 and cholorquine, rheumatoid arthritis treatment, 6- DINNING W J see DAVIES P G et al month comparative study 200 Disability, measures, in arthritis 563 in rheumatoid arthritis treatment, outcome 398 Disodium aurothiomalate, treating rheumatoid arthritis, DAVIES D FELIX- see FELIX-DAVIES D free thiomalate levels 698 DAVIS J M and PEEL M M Bacterial confirmation of DIXON J S see SITTON N G et al gonococcal arthritis: correspondence 537 DJALDETrI M see PEREK J et al Index 865

DNA and/or RNA content, increased, synovial fluid cells, ERHARDT C C, MUMFORD P and MAINI R N Differences in rheumatoid arthritis, flow-cytometry study 222 immunochemical characteristics of cryoglobulins in DODDS W see DYER P et al rheumatoid arthritis and systemic lupus erythemato- DOHERTY M see DIEPPE P A et al sus and their complement binding properties 451 Dorsolumbar spine, vertebral rim lesions 302: cor- ERKEN E see AKOdLU T et al respondence 662 ERSANLI M see YAZICI H et al DOWNES J see LOWTHIAN P et al ESKOLA J see VUENTO R et al DRosos A A see MOUTSOPOULOS H M et al ESSEN R VON see VON ESSEN R DRYLL A see BARDIN T et al EUCH M EL see EL EUCH M DUBY S see FITZCHARLES M A et al EULDERINK F see STEVEN M M et al DUNN N A, MAHIDA B H, MERRICK M V and NUKI EVANS H B, AYAD S, WEISS J B and HOLT P J L G Quantitative sacroiliac scintiscanning: a sensitive Localisation of collagen types, fibronectin, and pro- and objective method for assessing efficacy of non- teoglycans in cartilage 107 P steroidal, anti-inflammatory drugs in patients with EVRIN P E and STROM T P2-Microglobulin and its binding sacroiliitis 157 activity in serum from patients with SLE 267 DUR6 J C Arthritis and angioimmunoblastic lympha- denopathy: correspondence 536 Facsimile synovium, clearance of calcium pyrophosphate DUTrON J see BULGEN D Y et al crystals 487 DYER P, GRENNAN D M, WALTON K, KLIMIUK P, DODDS FAGAN E A see SEE PARKE A L et al W, CLAGUE R and HARRIS R HLA and properdin FAIRBANK J C T, PYNSENT P B and PHILLIPS H Quantita- factor B (Bf) in rheumatoid arthritis 118 P tive measurements of joint mobility in see also KLIMIUK P S et al adolescents 288 FALUS A see MERETEY K et al FARR M, HOLLYWELL C A, MORRIS C J, STRUTHERS G R, Ear, middle, arthritis, in ankylosing spondylitis: case BACON P A and WALTON K W Whipple's disease report 658 diagnosed at hip arthroplasty: case report 526 EASTMOND C J see HULL R G et al see also ROWLEY D et al EDWARDS J C W Abnormalities of microvascular filtra- FAURE G see ALBISER G et al tion in subjects with connective tissue disease 109 P Fc-receptor expression in rheumatoid arthritis 424 and SNAITH M L Microvascular filtration in subjects Feet, pressures, foil pedobarography 816 with connective tissue disorders 576 FEIGENBAUM P see FRIES J F et al see also SEDGWICK A D et al FELIX-DAVIES D see WRIGHT A et al EGNER E see HERWIG J et al Felty's syndrome ERHRENFELD M, UROWITZ M G and PLAITS M E Selective associated with high levels of IgA rheumatoid factor: C4 deficiency, systemic lupus erythematosus, and case report 505 Whipple's disease: case report 91 HLA antigens 120 P EISBRUCH A see PEREK J et al IgE class immune complexes, characterisation of anti- EL EUCH M see HAMZA M et al body activities in isolated complexes 246 Electrical nerve stimulation, transcutaneous, in Fenclofenac, nephrotic syndrome and renal impairment: osteoarthrosis 47 case report 513 Electromyography in leg muscle activity 63 FERRACCIOLO G F, CAVALIERI F, MERCADANTI M and ELFORD P R see RICHARDSON H J et al AMBANELLI U Osteosclerosis and new bone forma- ELKON K B, GHARAVI A E, HUGHES G R V and tion in young onset and late onset rheumatoid arthritis MOUTSOUPOULOS H M Autoantibodies in the sicca according to rheumatoid factor seropositivity: syndrome (primary Sjogren's syndrome) 243 correspondence 661 ELLIS L D see ROSENBAUM L H et al FERRELL W R see WOOD L and FERRELL W R ELLIS M I see MUNTON J S et al FERRIE J E see COLLINS A J et al ELSON C J see CARTER S D et al Ferritin, extracellular, role in inflammation 107 P ELSTON C W see GRIFFITHS H T et al Fibre glass induced synovitis: case report 530 EMERY P, PANAYI G S, HUSTON G and MITCHELL S Gene- Fibrin(ogen)olysis tic determinants of D-penicillamine (DP) toxicity in in polymyalgia rheumatica and temporal arteritis 721 rheumatoid arthritis 113 P plasma, decreased, in rheumatoid arthritis 774 SYMMONS D and BROWN G Mechanisms of depressed Fibrocartilage and articular cartilage, high-angle x-ray delayed-type hypersensitivity in rheumatoid arthritis: diffraction 802 the role of protein energy malnutrition 430 Fibronectin and proteoglycans, localisation in Employment, in ankylosing spondylitis 604 cartilage 107 P ENGLAND J P S see BERNSTEIN R M et al 'Fibrositis' syndrome, carpal tunnel syndrome and subse- Enteritis, occult, demonstrated by .. indium leucocyte quent rheumatoid arthritis 232 scanning, yersinia arthritis: case report 493 FIELD E see CALIN A et al Eosinophil cationic protein, in inflammatory synovial FISHER W D see BROMLEY M et al effusions, as evidence of eosinophil involvement 556 FITZCHARLES M, BANKS E, ST PIERRE J, DENT R and ERASMUS M G see MOOLENBURGH J D et al OSTERLAND C K A double-blind comparison of 866 Index

transcutaneous electrical nerve stimulation (TENS) GARRETr I R see VERNON-ROBERTS B et al and placebo in soft tissue rheumatism 110 P Gastric carcinoma, occult, presenting as an acute rheuma- FrrZCHARLES M A, DUBY S, WADDELL R W, BANKS E and tic disorder, malignant myositis ossificans: case KARSH J Limitation of joint mobility (cheiroarthro- report 95 pathy) in adult noninsulin-dependent diabetic GATHERCOLE L J see NICHOLLS S P et al patients 251 GAUCHER A see ALBISER G et al FLEMING A see DE JAGER J P et al GEDDES R see THOMAS D et al DE JAGER J P and FLEMING A GEMMELL C G see STEVEN M M et al MCGUIGAN L and FLEMING A General practitioners (GPs), rheumatology training, an Fluorescent antinuclear antibodies (FANA) tests, evaluated programme 110 P technique-related variation in results 755 Genetic Foil pedobarography, for feet pressures 816 linkage studies, familial rheumatoid arthritis 118 P FOLEY J A and PAYNE C M E R Unusual case of markers, pauciarticular onset juvenile chronic dermatomyositis: correspondence 662 arthritis 119 P FONTAGNE J see JAFFRAY P et al GERSTER J C, RAPPOPORT G and GINALSKI J M Prevalence FORBES C D see BELCH J J F et al of periarticular calcifications in pyrophosphate arthro- FORBES M see DE CEULAER K et al pathy and their relation to nodal osteoarthrosis 255 FORDHAM J N see DAVIES P G et al GERSTER J C see GOBELET C and GERSTER J C PEASE C T et al GHARAvI A E, CAMPION and HUGHES G R V Use of FORSKIFT S see HAWKINS S et al anti-idiotypic antibodies to demonstrate rheumatoid FOTHERBY K see MACKWORTH-YOUNG C G et al factor producing bone marrow cells in essential mixed FOWLER P D, SHADFORTH M F, CROOK P R and LAWTON cryoglobulinaemia: case report 651 A Report on chloroquine and dapsone in the treat- see also ELKON K B et al ment of rheumatoid arthritis: a 6-month comparative HARRIS E N et al study 200 HULL R G et al FRANCOEUR A M see BERNSTEIN R M et al GIANNINI E H, BREWER E J and PERSON D A Blood gold FRANKEN C K see MACFARLANE J D et al concentrations in children with juvenile rheumatoid FRANKS J J see GRAu R G et al arthritis undergoing long-term oral gold therapy 228 FRASER J R E see CLARRIS B J et al Giant cell arteritis, and abnormal radionuclide liver FRIES J F, WASNER C, BROWN J and FEIGENBAUM P A scans 583 controlled trial of antihypertensive therapy in systemic GIBSON T see GRAHAME R et al sclerosis (scleroderma) 407 GIJ6N J see PEN1A J M et al FRITZLER M J see KINSELLA T D et al GILMAN S C, DANIELS J F, WILSON R E, CARLSON R P and FROEBEL K, DICKSON R, LEWIS D, JASANI M K and LEWIS A J Lymphoid abnormalities in rats with STURROCK R D Characteristics of spontaneously adjuvant-induced arthritis. I. Mitogen responsiveness proliferating mononuclear cells in rheumatoid and lymphokine synthesis 847 arthritis 703 GINALSKI J M see GERSTER J C et al FROUDE G see HULL R G et al GIOTAKI H see MOUTSOPOULOS H M et al Frozen shoulder GIRAUDON B BECQ- see BECQ-GIRAUDON B arthrographic and radionuclear scan assessment 365 Glandular or rheumatic fever, history: corres- long-term prospective study 361 pondence 124 prospective clinical study with evaluation of three Glomerulonephritis, mesangial, association with haema- treatment regimes 353 turia in rheumatoid arthritis 440 FRUSTACI A see MAGARO M et al Glycosaminoglycan production and lysosomal activity of Functional ability (disability), in arthritis, in relation to human synovial cells in culture, stimulation by low impairment of range of joint movement 563 environmental pH 313 FURST D E, CLEMENTS P J, SAAB M, STERZ M G and GOBELET C and GERSTER J C Synovial fluid lactate levels PAULUS H E Clinical and serological comparison of in septic and non-septic arthritides 742 17 chronic progressive systemic sclerosis (PSS) and 17 GODDARD D H, KIRK A P, BROWN K A, MCCARTHY D, CREST syndrome patients matched for sex, age, and JOHNSON G D and HOLBOROW E J Changes in normal disease duration 794 polymorphonuclear leucocyte motility after ingestion of IgG aggregates 146 GALE R, BERTOUCH J V, GORDON T P, BRADLEY J and KIRWAN J R, JOHNSON G D and HOLBOROW E J Im- ROBERTS-THOMSON P J Neutrophil activation by im- paired polymorphonuclear leucocyte chemotaxis in mune complexes and the role of rheumatoid rheumatoid arthritis 151 factor 34 GOFrON J P see LOWTHIAN P et al GALLAGHER P J see ALLISON M C and GALLAGHER P J Gold GALLUS A S see THOMAS D et al blood concentrations, in children with juvenile rheuma- GALON Y see MORE R et al toid arthritis undergoing long-term oral gold GARANCIS J C see HALVERSON P B et al therapy 228 GARCIA-ALEGRIA J see PENA J A et al compounds, effect on respiratory burst of phagocytic GARDNER D L see O'CONNOR P et al cells 112 P Index 867

drugs, in adjuvant-induced polyarthritis, influence of rat guinea-pigs with circulating immune complexes from

strain and arthritogen on action 111 P patients with rheumatoid arthritis 749 exacerbates adjuvant arthritis, rat: corres- Haematuria, in rheumatoid arthritis, association with pondence 350 mesangial glomerulonephritis 440 and hypogammaglobulinaemia 581 Haemochromatosis and pyrophosphate deposition disease, nephropathy, due to Auranofin obscured by tolmetic arthropathy of: correspondence 536 pseudoproteinuria: case report 511 HAJIROUSSOU V J see WEBLEY M Prolonged low-dose in rheumatoid arthritis treatment, outcome 398 corticosteroid therapy and osteoporosis in rheumatoid ischaemic colitis and immune complexes during: case arthritis 24 report 495 HALKJAER-KRISTENSEN J see PETERSEN J et al GOLDRING S R see CRISP A J et al HALL M A see BURGOS-VARGOS R et al GOLDSMITH M R see CANOSO J J et al HALL N D, MCKEOWN M J and CORVALAN J F Sulphydryl Gonococcal arthritis, bacterial confirmation: corres- (SH)-dependent lymphocyte-monocyte interactions pondence 537 modulate antibody synthesis in rheumatoid GORDON T P see GALE R et al patients 116 P see also AHERN M J et al South African blacks 394 HAWKINS S et al and William Harvey 125 HALL P J, BURMAN S J, LAURENT M R, BRIGGS D, VENNING Gow P J see BARBER K E et al H, LEAK A and ANSELL B M Genetic markers in MCGUIGAN L E et al pauciarticular onset juvenile chronic arthritis 119 P GOWEN M see RICHARDSON H J et al HALLGREN R, BJELLE A and VENGE P Eosinophil cationic GRAHAME R, GIBSON T, DALE E, BROWN, R, ANDERSON protein in inflammatory synovial effusions as evidence J A D, CURWEN M and HIGGINS P An evaluated of eosinophil involvement 556 programme of rheumatology training for general HALLIWELL B see ROWLEY D et al practitioners (GPs) 110 P HALVERSON P B, GARANCIS J C and MCCARTY D J Histo- GRAN J T, HUSBY G, HORDVIK K, ST0RMER J and pathological ultrastructural studies of synovium in ROMBERG-ANDERSEN 0 Radiological changes in men Milwaukee shoulder syndrome-a basic calcium phos- and women with ankylosing spondylitis 570 phate 734 GRAU R G, KASSAN S S, FRANKS J J, KAPLAN H, WALKER HAMBLIN T J see SATrAR M A et al S H and TAN E M Fibrin(ogen)olysis in polymyalgia HAMZA M, AYED K, EL EUCH M, MOALLA M and BEN rheumatica and temporal arteritis: preliminary find- AYED H Synovial fluid complement levels in ings on association with disease activity 721 Behqet's disease: correspondence 767 GRAY D H see KATZ J M et al Hand, rheumatoid arthritis, microfocal radiographic ex- GRENNAN D M and AARONS L Salicylate-NSAID in- amination of erosions 160 teractions: correspondence 351 HANDLEY C J see BATES E J et al see also DYER P et al HANSEN T INGEMANN- see INGEMANN-HANSEN T KUMIUK P S et al HARRIS E N, GHARAVI A E, BOEY M L, PATEL GRIEVE D W and RASHDI T Pressures under normal feet B, MACKWORTH-YOUNG C, Loizou S and HUGHES in standing and walking as measured by foil G R V Anticardiolipin antibodies: detection by a pedobarography 816 new solid phase radioimmunoassay: striking associa- GRIFFIN A J, WOOLEY P, PANAYI G S and BATCHELOR tion with thrombosis 122 P J R HLA DR antigens and disease expression in see also HULL R G et al rheumatoid arthritis 218 HARRIS R see DYER P et al see also BLOWER P W and GRIFFIN A J KLIMIUK P S et al GRIFFITHS H T, ELSTON C W, COLTON C L and SWANNELL HARRISON R see Woo P et al A J Popliteal masses masquerading as popliteal HART F D William Harvey and his gout 125 cysts 60 HART H H see MCGUIGAN L E et al GRIFFITHS I D see HORDON L D et al Harvey, William, and his gout 125 PLATT P N and GRIFFITHS I D Hashimoto's thyroiditis and polyarthritis, possible subset GRIFFITHS M see ISENBERG D A et al of seronegative polyarthritis 594 GRIGOR R R see MCGUIGAN L E et al HASKARD D 0 and CURREY H L F Gold exacerbates GRINDULlS K A and MCCONKEY B Outcome of attempts adjuvant arthritis in the rat: correspondence 350 to treat rheumatoid arthritis with gold, penicillamine, HASLOCK I 'Seronegative spondarthritis': correspon- sulphasalazine, or dapsone 398 dence 662 see also ScoTr D L et al HAWKINS C F see PRIOR P et al GUMPEL J M see WILSON A P R et al SYMMONS D P M et al GUPTA S see BERNSTEIN et al HAWKINS S, FORSKITr S, HALL N D, MASLEN C, MADDISON GCRSAY A see AKOdLU T et al P J, MCGREGOR A R and BLACK C M Clinical and GUTTERIDGE J M see ROWLEY D et al laboratory effects of nifedipine in the treatment of Raynaud's phenomenon (RP) 110 P HAY S see VERNON-ROBERTS B et al HACK C E, LIM H G and AALBERSE R C Immunisation of HAYNES D R see VERNON-ROBERTS B et al 868 Index HAZELTON R A A study of lymphocytotoxins in families positive subjects, enhanced neutrophil migration in of patients with systemic lupus erythematosus 136 vivo 181 HAZEVOET H M see STEVEN M M et al DR antigens and disease expression, rheumatoid HAZLEMAN B L see BINDER A I et al arthritis 218 BULGEN D Y et al HOLBOROw E J see GODDARD D H et al DE SILVA M et al HOLLYWELL C A see FARR M et al JONES J et al HOLMES M W A see CLARRIS B J et al Heart cells, rat, cultured, antibodies to, in sera of HOLT P J L see EVANS H B et al rheumatoid arthritis patients 483 HOPKINS R see SHINEBAUM R et al HEATH J K, ATKINSON S J, MEIKLE M C and REYNOLDS Hopp A see ISENBERG D A et al J J Possible role of osteoblasts in bone HOPPE R see CALIN A et al resorption 105 P HORDON L D, SELLARS L, MORLEY A R, WILKINSON R, HEBERDEN SOCIETY THOMPSON M and GRIFFITHS I D Haematuria in Annual General Meeting and Oration, London, rheumatoid arthritis: an association with mesangial November 1983, proceedings 105 glomerulonephritis 440 Oration 1983: HLA as regulator 665 HORDVIK M see GRAN J T et al HELLIWELL M, COOMBES E J, MOODY B J, BATSTONE G R HORN P see ALBISER G et al and ROBERTSON J C Nutritional status in patients HORNE S see KEMP A S et al with rheumatoid arthritis 386 HOUGH D see MADDISON P J et al HENNEKENS C see LIANG M H et al HOWELL D S see ALTMAN R D et al HENRY K see STODELL M A et al HUGHES G R V see BERNSTEIN R M et al Heparin, modulates response of cultured human ELKON K B et al trabecular bone cells to hormones 105 P GHARAVI A E et al modulating intracellular cyclic AMP, in human HARRIS E N et al trabecular bone cells and adherent rheumatoid HULL R G et al synovial cells 628 MACKWORTH-YOUNG C AND HERWIG J, EGNER E and BUDDECKE E Chemical changes HUGHES G of human knee joint menisci in various stages of MACKWORTH-YOUNG C et al degeneration 635 PARKE A L et al HULL R G, HARRIS E N, GHARAVI A E, TINCANI A, HIGGINS P see GRAHAME R et al ASHERSON R A, VALESINI G, DENMAN A M, FROUDE HILL W see THOMAS D et al G and HUGHES G R V Anticardiolipin antibodies: HILLS B A and BUTLER B D Surfactants identified in occurrence in Behcet's syndrome 746 synovial fluid and their ability to act as boundary RENNIE J A N, EASTMOND C J, HUTCHISON J M S and lubricants 641 SMITH F W Nuclear magnetic resonance (NMR) HILTON R C and BALL J Vertebral rim lesions in the tomographic imaging for popliteal cysts in rheumatoid dorsolumbar spine 302 arthritis 56 Hip HUNTER J A see PULLAR T et al arthroplasty, Whipple's disease diagnosis: case HURST N P, BESSAC B and NUKI G Monocyte superoxide report 526 anion production in rheumatoid arthritis: preliminary joint, incongruous, a loading study 295 evidence for enhanced rates of superoxide anion Histiocytosis, malignant, intestine, and rheumatoid production by monocytes from patients receiving arthritis: correspondence 766 penicillamine, sodium aurothiomalate and HLA corticosteroids 28 antigens, Felty's syndrome 120 P HUSBY G see GRAN J T et al rheumatoid arthritis, in normal or elevated serum HUSTON G see EMERY P et al antibody levels to native type II collagen 119 P HUTCHISON J M S see HULL R G et al genetics, Class I molecules, and findings in leprosy: HUTTON C see DIEPPE P A et al Heberden 665 HUTFON C W see CARTER S D et al Oration 1983 HUTrON W C see AFOKE N Y P et al and immunoglobulin G heavy chain, in rheumatoid Hyaline articular cartilage dissected by papain, light and arthritis, epidemiological study 613 scanning electron microscopy and micromechanical and properdin factor B (Bf), rheumatoid arthritis 118 studies 320 p Hydrocortisone, effects of local administration on cartilage types, palindromic rheumatism: correspondence 538 degradation in vivo 418 A and B loci, juvenile chronic arthritis previously tissue Hypersensitivity, depressed delayed-type, mechanisms in typed, sacroiliac changes at 10-year follow-up 119 P rheumatoid arthritis, role of protein energy B27, ankylosing spondylitis, and polymorphonuclear cell malnutrition 430 motility 279 Hypertension, pulmonary, fatal, and lupus anticoagulant, polypeptides, two-dimensional gel analysis in demon- pulmonary thromboembolism 760 stration of non-structural alteration between Hypogammaglobulinaemia, associated with gold ankylosing spondylitis and normal 177 therapy 581 Index 869 Idiotypic cross-reactions, monoclonal human lupus Iron, lipid peroxidation, and inflammatory joint autoantibodies 122 P disease 108 P Immune complexes Ischaemic colitis and immune complexes, during gold and ischaemic colitis, during gold therapy for rheuma- therapy for rheumatoid arthritis: case report 495 toid arthritis: case report 495 ISENBERG D A, ROWE D, TOOKMAN A, Hopp A, GRIFFITHS neutrophil activation, role of rheumatoid factor 34 M, PAICE E, STEWART J and BEVERLEY P C L An rheumatoid arthritis, and immunisation of guinea- immunohistological study of secondary Sjogren's pigs 749 syndrome 470 see BOGHOSSIAN S H et al from SLE patients, effects on human monocyte locomo- SHOEFELD Y et al tion and Fc receptor function 729 IVESON J M I see TAGGART A J et al Immune deposits, dermoepidermal junction, in rheuma- toid arthritis: correspondence 537 JAFFRAY P, RONOT X, ADOLPHE M, FONTAGNE J and Immunoglobulins LECHAT P Effects of D-penicillamine on growth and A rheumatoid factor, Felty's syndrome: case cell cycle kinetics of cultured rabbit articular report 505 chondrocytes 333 rheumatoid factor, prognostic value 673 JAGER J P DE see DE JAGER J P E class immune complexes, Felty's syndrome, character- JAKOBY R K see JONES V et al isation of antibody activities in isolated JASANI M K see FROEBEL K et al complexes 246 JAYSON M I V see JONES C J P et al G aggregates, changes in normal polymorphonuclear JONES C J P and JAYSON M I V leucocyte motility after ingestion 146 JOHNSON G D see GODDARD D H et al -containing cells, increased numbers in rectal lamina JOHNSTON C see CHAIAMNUAY P et al propria of ankylosing spondylitis 172 DAVIS P et al heavy chain and HLA, in rheumatoid arthritis, Joint epidemiological study 613 and bone symptoms, Paget's disease 769 (M, G, and A) in yersinia arthritis and ankylosing mobility (cheiroarthropathy), limitation in adult spondylitis 186 noninsulin-dependent diabetes 251 secretion, spontaneous and induced, by synovial fluid B quantitative measurements, adolescents 288 lymphocytes in rheumatoid arthritis 140 movement, impairment of range, and measures of Immunosuppressive therapy, lupus nephritis 121 P disability in arthritis 563 Implant surgery, hand and upper extremity, 15th Annual JONES C J P and JAYSON M I V Chloroquine: its effect on International Symposium, Michigan, October 1984, leucocyte auto- and heterophagocytosis 205 announcement 540 SALISBURY R S and JAYSON M I V The presence of "'Indium leucocyte scanning, demonstrating occult enteri- abnormal lysosomes in lymphocytes and neutrophils during chloroquine therapy: a quantitative ultra- tis, yersinia arthritis: case report 493 structural study 710 Infection and interferon production, systemic juvenile JONES E L see SYMMONS D P M et al chronic arthritis, prospective study 1 JONES J, KYLE M V, HAZLEMAN B L and WRAIGHT Infective endocarditis, rheumatological manifestations P Abnormal radionuclide liver scans in giant cell 716 arteritis 583 Inflammation JONES V, TAYLOR P C R, JACOBY R K and WALLINGTON influence of prednisolone (PRED) and methotrexate T B Synovial synthesis of rheumatoid factors and (MTX) 112 immune complex constituents in early arthritis 235 role for extracellular ferritin 107 P JONGH B M DE see DE JONGH B M Inflammatory joint disease JOYCE C R B see KIRWAN J R et al caeruloplasmin 108 P JUBB R W Differential responses of human articular iron, and lipid peroxidation 108 P cartilage to retinol 833 synovial effusions, eosinophil cationic protein as evi- Juvenile rheumatoid arthritis dence of eosinophil involvement 556 blood gold concentrations in children undergoing long- INGEMANN-HANSEN T see PETERSEN J et al term oral gold therapy 228 Interferon production and infection, systemic juvenile chronic pauciarticular onset, genetic markers 119 P chronic arthritis, prospective study 1 previously tissue typed for HLA-A and B loci, Interleukin-1/mononuclear cell factor, human, partially sacroiliac changes at 10-year follow-up 119 P purified, modulating connective tissue turnover 106 systemic, infection and interferon production, p prospective study 1 Intervertebral discs and transient Brown's syndrome: case report 764 age distribution of amyloid: correspondence 663 degenerated annulus fibrosus contains collagen type KAMEL M see BASSIOUNI M and KAMEL M II, 258: correction 540 KAPLAN H see CALIN A et al Intestine, malignant histiocytosis, and rheumatoid arthri- GRAu R G et al tis: correspondence 766 KARSH J see FITZCHARLES M A et al 870 Index

KASSAN S S see GRAu R G et al KORST J K VAN DER see VAN DER KORST J K KATZ J M, SKINNER S J M, WILSON T and GRAY KOSKIMIES S see VUENTO R et al D H Inhibition of prostaglandin action and bone KRANE S M see CRISP J et al resorption by copper 841 KRISTENSEN J HALKJAER- see HALKJAER-KRISTENSEN J KAVAI M see LuKAcs K et al KUSHNER I see KHAN M A et al KEAT A C S see BUTLER R C et al KYLE M V see JONES J et al KELLER F see LENZ T and KELLER F KEMP A S, SEARLE C and HORNE S Transient Brown's LACHMANN P J see Woo P et al syndrome in juvenile chronic arthritis: case Lactate levels, synovial fluid, in septic and non-septic report 764 arthritides 742 KENNEDY N S J see REID D M et al Laminin and vascular changes KHAN M A, YAMASHITA T S and KUSHNER I Genetic in synovial inflammation 109 P linkage studies of familial rheumatoid arthritis 118 P proliferation, in rheumatoid arthritis 551 KIDD B L see MCGUIGAN L E et al LANGE G G DE see DE LANGE G G KIISTALA U see KOIVURANTA-VAARA P et al LANSAMAN J see BARDIN T et al Kingella kingae infection, knee, pitfall in purulent arthritis: LANTEIGNE C see KINSELLA T D et al case report 656 LARSON M see LIANG M H et al KINSELLA T D, LANTEIGNE C, FRITZLER M J and LEWKONIA LATrA L see ALTMAN R D et al R M Absence of impaired lymphocyte transforma- LAUFER A see MORE R et al tion to Klebsiella spp. in ankylosing spondylitis 590 LAURENT M R see HALL P J et al KIRK A P see GODDARD D H et al LAWTON A see FOWLER P D et al KIRWAN J R, CHAPUT DE SAINTONGE M, JOYCE C R B and LEADER M, REVELL P and CLARKE G Synovial infection CURREY H L F Clinical judgment in rheumatoid with Mycobacterium kansasii 80 arthritis. III. British rheumatologists' judgments of LEAK A see HALL P J et al 'change in response to therapy' 686 LECHAT P see JAFFRAY P et al and CURREY H L F Clinical judgment in rheumatoid LEEUWEN A W F M VAN see VAN LEEUWEN A W F M arthritis. IV. Rheumatologists' assessments of disease Leg muscle activity, electromyography 63 remain stable over long periods 695 LEINO R see VUENTO R et al see DAVIES P G et al LEIRISALO M see KOIVURANTA-VAARA P et al GODDARD D H et al LEJEUNE E see BONVOISIN B et al THOMPSON P W et al LENNIE S E see STEVEN M M et al Klebsiella carriage, ankylosing spondylitis, modification by LENZ T and KELLER F Tachyarrhythmia in yersinia diet, correlation of klebsiella carriage with disease arthritis: correspondence 535 activity 196 Leprosy, rheumatoid arthritis and HLA: Heberden Ora- Klebsiella spp., in ankylosing spondylitis, and absence of tion 1983 665 impaired lymphocyte transformation 590 LERICHE N see KLIPPEL J H et al KLIMIUK P see DYER P et al LERICHE N G H and BELL D A Hashimoto's thyroiditis KLIMIUK P S, CLAGUE R B, WALTON K, GRENNAN D M, and polyarthritis: a possible subset of seronegative DYER P, SMEATON I and HARRIS P HLA antigens in polyarthritis 594 rheumatoid arthritis patients with normal or elevated Lesotho, rheumatoid arthritis 40 serum antibody levels to native type II collagen 119 LEWIS A J see GILMAN S C et al p LEWIS B see LEWIS D et al KLIPPEL J H, AUSTIN H A, LERiCHE N, BALOW J E and LEWIS D, LEWIS B and STURROCK R D Transcutaneous DECKER J L Immunosuppressive therapy of lupus electrical nerve stimulation in osteoarthrosis: a ther- nephritis 121 P apeutic alternative? 47 KLOUDA P T, CORBIN S, BRADLEY B A, AHERN M J and see also CAPELL H A et al MADDISON P J HLA antigens in Felty's syn- FROEBEL K et al drome 120 P LEWKONIA R M see KINSELLA T D et al Knee LIANG M H, STOKER V, LARSON M, WILLET-r W, SPEIZER joint menisci, human, chemical changes in various stages F and HENNEKENS C Oestrogen-use, menopausal of degeneration 635 status, and relationship to rheumatoid arthritis 115 P response of slowly adapting articular mechanorecep- LIM H G see HACK C E et al tors to alterations in intra-articular volume, Lipid peroxidation, iron, and inflammatory joint cat 327 disease 108 P Kingella kingae infection, pitfall in purulent arthritis: Liposomes, chelator, 177Lu, in treatment of experimental case report 656 arthritis, rabbit 111 P KNIGHT C G see BARD D R et al Listeria monocytogenes , following intra- KOIvURANTA-VAARA P, REPO H, LEIRISALO M, KIISTALA U, articular yttrium-90 therapy: case report 518 OSTERMAN T and VAPAATALO H Enhanced neut- Liver scans, radionuclide, abnormal, in giant cell rophil migration in vivo HLA B27 positive arteritis 583 subjects 181 LLEWELLYN D H see COLLINS A J et al KOOTA K see SALMINEN I et al LoIzoU S see HARRIS E N et al Index 871 Low back pain, ankylosing spondylitis, sacroiliac tests, 2 MACKWORTH-YOUNG C and HUGHES G History of studies 192 rheumatic or glandular fever: correspondence 124 LOWE G D 0 see BELCH J J F et al see also HARRIS E N et al LoWTHER D A see BATES E J et al MACKWORTH-YOUNG C G, PARKE A L, MORLEY K D, LoWTHIAN P, WOOLF A, DOWNES J, GoFrON J P and CALIN FOTHERBY K and HUGHES G R V Sex hormones in A 'Seronegative rheumatoid arthritis (RA)'-a dis- men with SLE and other chronic diseases 115 P tinct radiological entity: a controlled study versus see also BERNSTEIN R M et al seropositive disease 117 P MCLAUGHLIN K see BELCH J J F et al '77Lu in chelator liposomes, in treatment of experimental MADAIO M P see SHOENFELD Y et al arthritis, rabbit 111 P MADDISON P J, SKINNER R P, BRENNAND D and HOUGH LuKAcs K, KAVAI M, BANYAi A, SONKOLY I, ViGH E, D Frequency of autoantibodies to nRNP, Sm, SZAB6 G and SZEGEDi G Y Effects of immune Ro(SSA), and La(SSB) in connective tissue diseases complexes from SLE patients on human monocyte using an ELISA technique 122 P locomotion and Fc receptor function 729 see also AHERN M J et al LUNEC J see BLAKE D R et al HAWKINS S et al WINYARD P et al KLOUDA P T et al Lupus MOUTSOPOULOS H M et al anticoagulant, pulmonary thromboembolism, and fatal RIDLEY M G et al pulmonary hypertension 760 MADHOK R, PULLAR T, CAPELL H, STURROCK R and DICK autoantibodies, monoclonal human, idiotypic cross- H Chrysotherapy and thrombocytopenia 113 P reactions 122 P see also BELCH J J F et al nephritis, immunosuppressive therapy 121 P CAPELL H A et al LYLE W H Fatal bronchiolitis obliterans associated with MAGAR6 M, CERESIA G and FRUSTACi A Arthritis of the chrysotherapy: correspondence 351 middle ear in ankylosing spondylitis: case report 658 Lymphadenopathy, angioimmunoblastic, and arthritis MAHIDA B H see DUNN N A et al correspondence 536 MAIER J see CHAIAMNUAY P et al Lymphocytes MAINi R N see ERHARDT C C et al and serum factors, role in vasculitic diseases 116 P MELSOM R D et al transformation, impaired, transformation to Klebsiella MAJOR G A C see BOGDUK N et al spp., absence in ankylosing spondylitis 590 MALAVIYA A N see PRAKASH S et al Lymphocytotoxins, in families of patients with systemic MALCOLM L P see CLARRIS B J et al lupus erythematosus 136 MASLEN C see HAWKINS S et al Lymphoid abnormalities, in adjuvant-induced arthritis, Mast cells, at sites of cartilage erosion, rheumatoid rats. I. Mitogen responsiveness and lymphokine joint 76 synthesis 847 MATHEWS M B see BERNSTEIN R M et al Lymphoproliferative malignancy, rheumatoid arthritis, 20 MAVRIDiS A C see MOUTSOPOULOS H M et al cases 132 MAYO K M see BARBER K E et al Lysosomal activity and glycosaminoglycan production of MEATS J E see RiCHARDSON H J et al human synovial cells in culture, stimulation by low Mechanoreceptors, articular, slowly adapting, cat knee environmental pH 313 joint, response to alterations in intra-articular volume 327 MEDSGER T A see BRANDWEIN S R et al MCARDLE B see BELCH J J F et al MEHRA N K see PRAKASH S et al MCCARTHY D see GODDARD D H et al MEIKLE M C see HEATH J K et al D P B et MCCARTY J see HALVERSON al MELSOM R D, SMITH P R and MAINi R N Analysis of MCCONKEY B see GRINDULiS K A and MCCONKEY B MACFARLANE D G and SErrAs L Acute psoriatric arthro- circulating immune complexes isolated by affinity chromatography from the sera of rheumatoid arthritis pathy precipitated by oxprenolol: case report 102 see also DIEPPE P A et al patients 116 P MACFARLANE J D, FRANKEN C K and VAN LEEUWEN Menopausal status, oestrogen-use, and relationship to A W F M Progressive cavitating pulmonary changes rheumatoid arthritis 115 P in rheumatoid arthritis: case report 98 MENS J and VAN DER KORST J K Calcifying supracor- MCGILL P E see BROUGHAM P A et al acoid bursitis as a cause of chronic shoulder pain: case MCGREGOR A R see HAWKINS S et al report 758 MCGUIGAN L and FLEMING A Pericardial mesothelioma MERCADANTI M see FERRACCIOLI G F et al presenting as systemic lupus erythematosus: case MERtTEY K, FALUS A, BOHM U, PERMIN H and WIIK report 515 A IgE class immune complexes in Felty's syndrome: MCGUIGAN L E, HART H H, Gow P J, KIDD B L, GRIGOR characterisation of antibody activities in isolated R R and MOORE T E Employment in ankylosing complexes 246 spondylitis 604 MERRICK M V see DUNN N A et al MCKENZIE I F C see TRAPANI J A et al Mesangial glomerulonephritis, association with haema- MCKEOWN M J see HALL N D et al turia in rheumatoid arthritis 440 872 Index Mesothelioma, pericardial, presenting as systemic lupus Musculoskeletal abnormalities, multiple, family with 275 erythematosus: case report 515 Mycobacterium kansasii, synovial infection 80 Metabolic bone disease, incidence in rheumatoid arthritis Myeloma, anaplastic, in systemic lupus erythematosus: and osteoarthritis 370, 117 P case report 653 Methylprednisolone therapy, high-dose, effect on phago- Myocrisin, and free thiomalate in plasma and urine 66 cyte function in systemic lupus erythematosus 541 Myositis ossificans, malignant, occult gastric carcinoma Microcrystal deposition, multiple, disease, with systemic presenting as an acute rheumatic disorder: case lupus erythematosus: case report 498 report 95 Microglobulin - binding activity in serum from patients with SLE 267 NAIDOO P D see MODY G M and NAIDOO P D Microvascular filtration, in connective tissue Natural killer cell activity, inhibition by systemic lupus disorders 576 erythematosus serum, roles of disease activity and MILLER C see DAVIS P et al serum interferon 457 Milwaukee shoulder syndrome, histopathological and Nephrotic syndrome and renal impairment associated with ultrastructural studies of synovium, basic calcium fenclofenac: case report 513 phosphate crystal arthropathy 734 NETFER P see ALBISER G et al MITCHELL S see EMERY P et al NEUMAN N V see SHINEBAUM R et al MITTELMAN M see PEREK J et al Neutrophil MOALLA M see HAMZA M et al activation by immune complexes, role of rheumatoid MODY G M and NAIDOO P D Gout in South African factor 34 blacks 394 migration, enhanced, in vivo HLA B27 positive MOHR W see WAGNER T and MOHR W subjects 181 Monocytes NEWBERG A H see CANOSO J J et al peripheral blood, rheumatoid arthritis, enhanced bac- Ng K C, REVELL P A, BEER M, BOUCHER B J, COHEN R D terial phagocytosis 435 and CURREY H L F Incidence of metabolic bone superoxide anion production, rheumatoid arthritis 28 disease in rheumatoid arthritis and osteoarthritis 370 Mononuclear cells see also REVELL P A et al factor/interleukin-1, human, partially purified, modulat- NICHOLAS J J see ROSENBAUM L H et al ing connective tissue turnover 106 P NICHOLLS S P, GATHERCOLE L J and SHAH J S Morpho- spontaneously proliferating, characteristics, in rheuma- logy of human palmaris longus tendon 477 toid arthritis 703 Nifedipine, clinical and laboratory effects in treatment of phagocytes, rheumatoid arthritis, Fc-receptor expres- Raynaud's phenomenon (RP) 110 P sion by peripheral blood monocytes 424 NISHIKAI M, OKANO Y, YAMASHrIA H and WATANABE MOODY B J see HELLIWELL M et al M Characterisation of centromere (kinetochore) MOOLENBURGH J D, MOORE S, VALKENBURG H A and antigen reactive with sera of patients with a sclero- ERASMuS M G Rheumatoid arthritis in Lesotho 40 derma variant (CREST syndrome) 819 MOORE A see SIN Y M et al see also OKANO Y et al MOORE A R and SEDGWICK A D et al NISSINEN A see SALMINEN I et al MOORE S see MOOLENBURGH J D et al Nodal osteoarthrosis, relationship with prevalence of MOORE T E see MCGUIGAN L E et al periarticular calcifications in pyrophosphate MORE R, STERN Z, GALON Y and LAUFER A Antibodies arthropathy 255 to cultured rat heart cells in sera of patients with Non-steroidal, anti-inflammatory drugs rheumatoid arthritis 483 in sacroiliitis, scintiscanning in assessing efficacy 157 MORLEY A R see HORDON L D et al salicylate interactions: correspondence 351 SELLARS L et al NORTON W L Brucellosis and rheumatic syndromes in MORLEY K D see MACKWORTH-YOUNG C G et al Saudi Arabia 810 MORRIS C J see FARR M et al NOTARIANNI L J see COLLINS A J et al Scorr D L et al Nuclear magnetic resonance (NMR), tomographic imag- MOUTSOPouLOS H M, GIOTAKI H, MADDISON P J, MAVRIDIS ing, popliteal cysts, rheumatoid arthritis 56 A C, DRosos A A and SKOPOULI F N Antibodies to Nucleoside triphosphate pyrophosphohydrolase, identi- cellular antigens in Greek patients with autoimmune fication in normal human articular chondrocytes in rheumatic diseases: anti-Ro(SSA) antibody a possible monolayer culture 107 P marker of penicillamine-D intolerance 285 NUKI G see DUNN N A et al see also ELKON K B et al HURST N P et al MUFTUOGLU A see YAZICHI H et al REID D M et al MUFrIOOLU A U see YAZICHI H et al Nutritional status, rheumatoid arthritis 386 MUIRDEN K D see CLARRIS B J et al MUMFORD P see ERHARDT C C et al MUNTON J S, ELLIS M I and WRIGHT V Use of electro- OBITUARY, Professor Gerald P. Rodnan 124 myography to study leg muscle activity in patients with OBLEY D L see ROSENBAUM L H et al arthritis and in normal subjects during rising from a O'CONNOR P, BRERETON J D and GARDNER D L Hyaline chair 63 articular cartilage dissected by papain: light and Index 873

scanning electron microscopy and micromechanical PARK H, SCHUMACHER H R, ZEIGER A R and ROSENBAUM studies 320 J T Antibodies to peptidogylcan in patients with Oestrogen-use, menopausal status, and relationship to spondylarthritis: a clue to disease aetiology? 725 rheumatoid arthritis 115 P PARKE A L, FAGAN E A, CHADWICK V S and HUGHES OKANO Y, NISHIKAI M and SATO A Scleroderma, primary G R V Coeliac disease and rheumatoid arthritis biliary cirrhosis, and Sjogren's syndrome after cos- 378 metic breast augmentation with silicone injection: a see also MACKWORTH-YOUNG C G et al case report of possible human adjuvant disease: case PARRY R see DE VERE-TYNDALL A et al report 520 PATEL B see HARRIS E N et al see also NISHIKAI M et al Pathergy reaction, and Behqet's syndrome, Britain 70 Olecranon brusitis, traumatic, corticosteroid injection, Turkish and British patients compared disease 74 long-term follow-up 44 PAUL H see RODRfGUEZ M A et al Osteoarthritis PAULUS H E see FURST D E et al experimentally induced, biomechanical and biochemical PAYNE C M E R see FOLEY J A and PAYNE C M E R properties of cartilage, dog 83 PAZARLI H see YAZICHI H et al and rheumatoid arthritis, incidence of metabolic bone PEASE C T, FORDHAM J N and CURREY H L F Polymor- disease 370, 117 P phonuclear cell motility, ankylosing spondylitis, and Osteoarthrosis HLA B27 279 nodal primary generalised, bone mass 240 Pedobarography, foil, for feet pressures 816 relationship with prevalence of periarticular calcifica- PEEL M M see DAVIS J M and PEEL M M tions in pyrophosphate arthropathy 255 PE*qA J M, GARCIA-ALEGRIA J, CRESPO M, GIJ6N J and transcutaneous electrical nerve stimulation 47 VAZQUEZ J J Spontaneous rupture of the spleen in Osteoblasts, possible role in bone resorption 105 P RA: correspondence 539 Osteomyelitis, pyogenic, presenting as an acute sterile Penicillamine (D) arthropathy 607 in rheumatoid arthritis treatment, outcome 398 Osteoporosis effects on growth and cell cycle kinetics of cultured Consensus Development Conference, Maryland USA, rabbit articular chondrocytes 333 April 1984, announcement 123 intolerance, anti-Ro(SSA) antibody a possible marker, in rheumatoid arthritis, prolonged low-dose cortico- antibodies to cellular antigens in Greek patients with steroid therapy 24 autoimmune rheumatic diseases 285 Osteosclerosis and new bone formation, in young and late pharmacokinetics, man 112 P onset rheumatoid arthritis, according to rheumatoid thrombokinetics in rheumatoid arthritis 402 factor seropositivity: correspondence 661 toxicity, in rheumatid arthritis, genetic determinants OSTERLAND C K see FITZCHARLES M et al 113 P OSTERMAN T see KOIVURANTA-VAARA P et al withdrawal, rheumatoid arthritis 213 Oxprenolol, precipitating acute psoriatric arthropathy: Peptidoglycan, antibodies in spondylarthritis 725 case report 102 PEREK J, MITrELMAN M, EISBRUCH A and DJALDETTI Oxygen free-radicals, mediate an inhibition of proteogly- M Systemic lupus erythematosus preceded by long- can synthesis in cultured articular cartilage 462 term cryoglobulinaemia: case report 339 OZCAN K see AKOOLU T et al PERMIN H see MERtTEY K et al OZDOOAN H see YAZICHI H et al PERNAMBUCO J C see SCHEINBERG M A et al OZER F L see AKO1LU T et al PERRETr D see RUDGE S R et al OZYAZGAN Y see YAZICHI H et al PERSON D A see GIANNINI E H et al PESKETr S A see So A K L et al PETERSEN J, INGEMANN-HANSEN T and HALKJAER- PAGE-THOMAs D P see BARD D R et al KRISTENSEN J Spontaneous and induced immunoglo- Paget's disease, bone and joint symptoms 769 bulin secretion by synovial fluid B lymphocytes in PAICE E see ISENBERG D A et al rheumatoid arthritis 140 Palindromic rheumatism, HLA types: correspon- dence 538 PETITALOT J P see THOMAS PH et al Palmaris longus tendon, human, morphology 477 Phagocyte PALMER D G and SCHUMACHER H R Synovitis with function in systemic lupus erythematosus, effect of non-specific histological changes in synovium in chro- high-dose methylprednisolone therapy 541 nic sarcoidosis 778 cells, respiratory burst, effect of gold compounds 112 P PANAYI G see EMERY P et al PHILLIPS H see FAIRBANK J C T et al PANAYI G S see EMERY P et al PIERRE J ST see ST PIERRE J GRIFFIN A J et al PLATT P N and GRIFFITHS I D Pyogenic osteomyelitis Papain, hyaline articular cartilage dissection, light and presenting as an acute sterile arthropathy 607 scanning electron microscopy and micromechanical PLATTS M E see EHRENFELD M et al studies 320 Polyarthritis Parasitic arthritis, induced by Strongyloides stercoralis: adjuvant-induced, influence of rat strain and arthritogen case report 523 on actions of gold drugs 111 P 874 Index and Hashimoto's thyroiditis, possible subset of thromboembolism, and fetal pulmonary hypertension, seronegative polyarthritis 594 lupus anticoagulant 760 Polymorphonuclear PYSENT P B see FAIRBANK J C T et al cell motility, ankylosing spondylitis, and HLA B27 279 Pyogenic osteomyelitis, presenting as an acute sterile leucocyte, chemotaxis, impaired, rheumatoid arthritis arthropathy 607 151 Pyrophosphate arthropathy, prevalence of periarticular motility, normal, changes after ingestion of IgG calcifications in, their relation to nodal aggregates 146 osteoarthrosis 255 Polymyalgia rheumatica and antimitochondrial antibodies 264 and temporal arteritis, fibrin(ogen)olysis in 721 Radiological POPERT A J see Scorr D L et al changes, rheumatoid arthritis, progression 8 Popliteal progression, rheumatoid arthritis, second-line therapy cysts, rheumatoid arthritis, nuclear magnetic resonance 18: correction 540 (NMR) tomographic imaging 56 Radionuclide liver scans, abnormal, in giant cell masses, masquerading as popliteal cysts 60 arteritis 583 POTASMAN I and BASSAN H M Multiple tendon rupture in RAJAPAKSE D A see TILIAKOS N A et al systemic lupus erythematosus: case report and review RAPPOPORT G see GERSTER J C et al of the literature: case report 347 RASHDI T see GRIEVE D W and RASHDI I POUPET J Y see THOMAS PH et al RAUCH J see SHOENFELD Y et al PRAKASH S, MEHRA N K, BHARGAVA S, VAIDYA M C and Raynaud's phenomenon (RP), treatment, clinical and MALAVIYA A N Ankylosing spondylitis in North laboratory effects of nifedipine 110 P India: a clinical and immunogenetic study 381 Red cell deformability, and prostacyclin levels, in systemic Prednisolone sclerosis 117 P dosage, timing, and morning stiffness, in rheumatoid REEVE J see Woo P et al arthritis 790 REID D M, KENNEDY N S J, SMITH M A, TOTHILL P and and methotrexate (MTX), influence on inflammation NUKI G Bone mass in nodal primary generalised 112 P osteoarthrosis 240 PRIOR P, SYMMONS D P M, HAWKINS C F, ScoTr D L and Reiter's syndrome, and trauma, development of 'reactive BROWN R Cancer morbidity in rheumatoid arthropathy' 829 arthritis 128 Renal impairment and nephrotic syndrome associated with see also SYMMONS D P M et al fenclofenac: case report 513 PRITCHARD M H Synovial protease/inhibitor ratios in RENNIE J A N see HULL R G et al erosive and nonerosive 50 REPo H see KOIVURANTA-VAARA P et al Proceedings Heberden Society, Annual General Meeting RESNICK D Arthropathy of calcium pyrophosphate de- and Oration, London, November 1983 105 position disease and of haemochromatosis: Properdin factor B (Bf) and HLA, rheumatoid correspondence 536 arthritis 118 P Retinol, differential responses of articular cartilage 833 Prostacyclin levels, and red cell deformability, in systemic Retrocalcaneal bursa, aspiration 308 sclerosis 117 P REVELL P see LEADER M et al Prostaglandin action, inhibition, and bone resorption by REVELL P A, Ng K C, BEER M, BOUCHER B J, COHEN R D copper 841 and CURREY H L F The incidence of metabolic bone Protein energy malnutrition, role in mechanisms of de- disease in rheumatoid arthritis and osteoarthritis 117 pressed delayed-type hypersensitivity in rheumatoid p arthritis 430 see also NG K C et al Proteoglycans REVILLARD J P see BONVOISIN B et al and fibronectin, localisation in cartilage 107 P REYNOLDS J J see HEATH J K et al synthesis, in cultured articular cartilage, oxygen free- Rheumatic radicals mediate inhibition 462 or glandular fever, history: correspondence 124 PROUSE P J see WILSON A P R et al syndromes and brucellosis, Saudi Arabia 810 Pseudothrombosis and shoulder joint rupture, rheumatoid Rheumatism, soft tissue, transcutaneous electrical nerve arthritis: case report 503 stimulation (TENS) and placebo, double-blind Psoriatric arthropathy, acute, precipitated by oxprenolol: comparison 110 P case report 102 Rheumatoid arthritis PULLAR T, HUNTER J A and CAPELL H A Does second- analysis of circulating immune complexes isolated by line therapy affect the radiological progression of affinity chromatography from sera 116 P rheumatoid arthritis? 18, 114 P correction 540 cancer morbidity 128 see also CAPELL H A et al chloroquine and dapsone treatment, 6-month compara- MADHOK R et al tive study 200 Pulmonary circadian variation in biochemical assessments 444 changes, progressive cavitating, in rheumatoid arthritis: clinical judgment. III. British rheumatologists' judg- case report 98 ments of 'change in response to therapy' 686: IV. Index 875

rheumatologists' assessments of disease remain stable radiological changes, progression 8 over long periods 695 radiological progression, second-line therapy 18: 114, and coeliac disease 378 P, correction 540 D-penicillamine withdrawal 213 second-line therapy, and 'intention to treat', four-year decreased plasma fibrinolysis 774 follow-up 114 P early. I. Prognostic value of IgA rheumatoid sera, antibodies to cultured rat heart cells 483 factor 673: II. Association of rheumatoid factor shoulder joint rupture and pseudothrombosis: case isotypes with fluctuations in disease activity 679 report 503 synovial synthesis of rheumatoid factors and immune with sicca syndrome, salivary scanning 610 complex constituents 235 spontaneous and induced immunoglobulin secretion by enhanced bacterial phagocytosis by peripheral blood synovial fluid B lymphocytes 140 monocytes 435 spontaneous rupture of spleen: correspondence 539 familial, genetic linkage studies 118 P spontaneously proliferating mononuclear cells, 'fibrositis' syndrome and carpal tunnel syndrome 232 characteristics 703 genetic determinants of D-penicillamine (DP) sulphydryl (SH)-dependent lymphocyte-monocyte in- toxicity 113 P teractions modulate antibody synthesis 116 P gold, penicillamine, sulphasalazine, or dapsone treat- and systemic lupus erythematosus and their complement ment, outcome 398 binding properties, characteristics of cryoglobulins haematuria in, association with mesangial glomerulo- 451 nephritis 440 thrombokinetics, D-penicillamine treatment 402 HLA antigens, in normal or elevated serum antibody total lymphoid irradiation (TLI), double-blind con- levels to native type II collagen 119 P trolled study 121 P DR antigens and disease expression 218 treated with disodium aurothiomalate, free thiomalate and immunoglobulin G heavy chain, epidemiological levels 698 study 613 and type 1 diabetes mellitus: correspondence 351 and properdin factor B (Bf) 118 P Rheumatoid factor immune deposits at dermoepidermal junction: IgA, Felty's syndrome: case report 505 correspondence 537 role, neutrophil activation by immune complexes 34 impaired polymorphonuclear leucocyte chemotaxis seropositivity, osteosclerosis and new bone formation in 151 young and late onset rheumatoid arthritis: increased DNA and/or RNA content of synovial fluid correspondence 661 cells, flow-cytometry study 222 synovial synthesis, immune complex constituents in ischaemic colitis and immune complexes during gold early arthritis 235 therapy: case report 495 Rheumatoid joint, mast cells at sites of cartilage laminin and vascular proliferation 551 erosion 76 lateral subluxation of atlas, case report and post-mortem Rheumatology study: case report 341 XVI International Congress, New South Wales, May Lesotho 40 1985, announcement 768 lymphoproliferative malignancy, 20 cases 132 Marisa Ara prize, announcement 540 and malignant histiocytosis of the intestine: Mediterranean Congress, Naples, June 1984, correspondence 766 announcement 352 mechanisms of depressed delayed-type hypersensitivity, 9th Panhellenic Congress, Athens, November 1984, role of protein energy malnutrition 430 announcement 540 microfocal radiographic examination of erosions in wrist research, 5th EULAR Workshop, Milan, March 1985, and hand 160 announcement 540 monocyte superoxide anion production 28 Symposium on current immunological concepts, mononuclear phagocytes in, Fc-receptor expression by Budapest, September 1984, announcement 352 peripheral blood monocytes 424 third Prague Symposium, June 1984, nuclear magnetic resonance (NMR) tomographic imag- announcement 352 ing for popliteal cysts 56 training for general practitioners (GPs), an evaluated nutritional status 386 programme 110 P oestrogen-use and menopausal status 115 P RICHARDs A J Carpal tunnel syndrome and subsequent and osteoarthritis, incidence of metabolic bone rheumatoid arthritis in the 'fibrositis' syndrome 232 disease 370, 117 P RIcHARDSON H J, ELFORD P R, SHARRARD R M, GOWEN M, osteoporosis in, prolonged low-dose corticosteroid MEATS J E and RUSSELL R G G Modulation of therapy 24 connective tissue turnover by partially purified human prednisolone dosage, timing, and morning stiffness 790 mononuclear cell factor interleukin-l 106 P presence of abnormal lysosomes in lymphocytes and RIDLEY J see WINYARD P et al neutrophils during chloroquine therapy, quantitative RIDLEY M G, MADDISON P J and TRIBE C R Amyloidosis ultrastructural study 710 and systemic lupus erythematosus: case report 649 progressive cavitating pulmonary changes: case RING E F J see COLLINS A J et al report 98 RISKIN W see ALTMAN R D et al 876 Index RNA SALMINEN I, VON ESSEN R, KOOTA K and NISSINEN A A antigens and cellular protein, in autoimmune pitfall in purulent arthritis brought out in Kingella disease 123 P kingae infection of the knee: case report 656 and/or DNA content, increased, synovial fluid cells, SALMON M see Scorr D G I et al rheumatoid arthritis, flow-cytometry study 222 SALMON M see Sco-rT D L et al ROBERTS B VERNON- see VERNON-ROBERTS B SALTER R H see SELLARS L et al ROBERTS S see BINDER A I et al Sarcoidosis, chronic, and synovitis, with non-specific BULGEN D Y et al histological changes in synovium 778 ROBERTS-THOMSON P J see GALE R et al SATO A see OKANO Y et al Robertson J C see HELLIWELL M et al SATrAR M A, CAWLEY M I D, HAMBLIN T J and ROBERTSON SATrAR M A et al J C Polymyalgia rheumatica and antimitochondrial RODNAN G P see BRANDWEIN S R et al antibodies 264 RODNAN, Professor Gerald P., obituary 124 SAVERYMUTU S H see BERNSTEIN R M et al RODRfGUEZ M A, PAUL H, ABADf I, BRAVo J R and ARMAS SCHEINBERG M A, PERNAMBUCO J C and BENSON P Multiple microcrystal deposition disease in a M D DMSO and colchicine therapy in amyloid patient with systemic lupus erythematosus: case disease 421 report 498 SCHNITZER T J see YTTERBERG S R and SCHNITZER T J ROELKE M S see CRISP A J et al SCHUMACHER H R see BARDIN T et al ROGERS K see CLARRIS B J et al PALMER D G and ROMBERG-ANDERSEN 0 see GRAN J T et al SCHUMACHER H R ROMUNDE L K J VAN see VAN ROMUNDE L K J PARK H et al RONOT X see JAFFRAY P et al SCHWARTZ R S see SHOENFELD Y et al ROOD J J VAN see VAN ROOD J J Scintiscanning, in assessing efficacy of NSAIDS in ROPER D see DE CEULAER K et al sacroiliitis 157 ROSENBAUM J T see PARK H et al Scleroderma, primary biliary cirrhosis, and Sjogren's ROSENBAUM L H, NICHOLAS J J, SLASKY B S, OBLEY D L syndrome, after cosmetic breast augmentation with and ELLIS L D Malignant myositis ossificans: occult silicone injection, possible human adjuvant disease: gastric carcinoma presenting as an acute rheumatic case report 520 disorder: case report 95 ScoTT D G I, BLAKE D R, BLANN A, SALMON N, RossI F see THOMAS PH et al BRAILSFORD S, WINYARD P and BACON P A The role ROTHFUSS S see BARDIN T et al of lymphocytes and serum factors in vasculitic ROWE D see ISENBERG D A et al diseases 116 P ROWLEY D, GUITERIDGE J M, BLAKE D R, FARR M and ScoTr D L, GRINDULIS K A, STRUTHERS G R, COULTON HALLIWELL B Iron, lipid peroxidation and in- B L, POPERT A J and BACON P A Progression of flammatory joint disease 108 P radiological changes in rheumatoid arthritis 8 Rubifacient, topical, 'deep-heat', observations on SALMON M, MOMIS C J, STEVEN M M and WALTON pharmacology 411 K W Laminin and vascular changes in synovial RUDGE S R, PERRETr D and SWANNELL A J Free inflammation 109 P thiomalate levels in patients with rheumatoid arthritis WAINWRIGHT A C and WALTON K W Laminin and treated with disodium aurothiomalate: relationship to vascular proliferation in rheumatoid arthritis 551 clinical outcome of therapy 698 see also PRIOR P et al Free thiomalate in plasma and urine of patients receiving SYMMONS D P M et al sodium aurothiomalate 66 SEARLE C see KEMP A S et al RUSSELL A S see CHAIAMNUAY P et al Second-line therapy, affecting radiological progression of RUSSELL R G G see CASWELL A M and RUSSELL R G G rheumatoid arthritis 18: 114 P correction 540 RICHARDSON H J et al rheumatoid arthritis, absence of placebo response, an obstacle to outcome measurement 114 P SAAB M see FURST D E et al SEDGWICK A D, SIN Y M, MOORE A R, EDWARDS J C W Sacroiliac and WILLOUGHBY D A Effects of local administra- changes, at 10-year follow-up of juvenile chronic tion of hydrocortisone on cartilage degradation in arthritis previously tissue typed for HLA-A and B vivo 418, 106 P loci 119 P SEED M P see COLLINS A J et al scintiscanning, in assessing efficacy NSAIDS in SEGAL A W see BOGHOSSIAN S H et al sacroiliitis 157 SEIFERT M H see TEITSSON I et al tests, ankylosing spondylitis, low back pain, 2 WITHRINGTON R H et al studies 192 SELLARS L, WILKINSON R, MORLEY A R and SALTER SAINTONGE D M, CHAPUT DE see CHAPUT DE SAINTONGE R H Nephrotic syndrome and renal impairment D M associated with fenclofenac: case report 513 Salicylate-NSAID interactions: correspondence 351 see also HORDON L D et al SALISBURY R S see JONES C J P et al SIN Y M et al Salivary scanning, in rheumatoid arthritis with sicca SERDARO0LU S see YAZICI H et al syndrome 610 SERJEANT G R see DE CEULAER K et al Index 877 Seronegative SKINNER S J M see KATZ J M et al rheumatoid arthritis, distinct radiological entity, con- SKOPOULI F N see MOUTSOPOULOS H M et al trolled study versus seropositive disease 117 P SLASKY B S see ROSENBAUM L H et al spondarthritis': correspondence 662 SMEATON I see KLIMIUK P S et al Serum factors and lymphocytes, role in vasculitic SMITH F W see HULL R G et al diseases 116 P SMITH K see CLELAND L G et al SETrAS L see MACFARLANE D G and SETTAS L SMITH M A see REID D M et al Sex hormones, in men with systemic lupus erythematosus SMITH P R see MELSOM R D et al and other chronic diseases 115 P SNAITH M L see BOGHOSSIAN S H et al SHADFORTH M F see FOWLER P D et al EDWARDS J C W and SNAITH M L SHAH J S see NICHOLLS S P et al So A K L, PESKETT S A and WEBSTER A D B Hypogam- SHARRARD R M see RICHARDSON H J et al maglobulinaemia associated with gold therapy 581 SHINEBAUM R, NEUMANN V, HOPKINS R, COOKE E M and Sodium aurothiomalate, free thiomalate in plasma and WRIGHT V Attempt to modify klebsiella carriage in urine 66 ankylosing spondylitic patients by diet: correlation of Soft tissue rheumatism, transcutaneous electrical nerve klebsiella carriage with disease activity 196 stimulation (TENS) and placebo, double-blind SHOENFELD Y, ISENBERG D A, RAUCH J, MADAIO M P, comparison 110 P STOLLAR B D and SCHWARTZ R S Idiotypic cross- SONKOLY I see LUKACS K et al reactions of monoclonal human lupus South African blacks, gout 394 autoantibodies 122 P SPEIZER F see LIANG M H et al Shoulder Spinal disorders, International course on diagnosis, treat- hand syndrome, and symmetrical arthralgia in tubo- ment and rehabilitation, Gothenburg, June 1984, ovarian carcinoma 391 announcement 352 joint rupture and pseudothrombosis, rheumatoid ar- Spleen, spontaneous rupture, rheumatoid arthritis: thritis: case report 503 correspondence 539 pain, chronic, caused by calcifying supracoracoid bur- Spondylarthritis sitis: case report 758 and antibodies to peptidoglycan 725 syndrome, Milwaukee, histopathological and ultra- seronegative: correspondence 662 structural studies of synovium, basic calcium phos- Spondylitis and brucellosis, Saudi Arabia 810 phate crystal arthropathy 734 ST PIERRE J see FITZCHARLES M et al Sicca syndrome (primary Sjogren's syndrome), autoanti- STAMP T C B see WINFIELD J and STAMP T C B bodies in 243 STERN Z see MORE R et al and rheumatoid arthritis, salivary scanning 610 STERZ M G see FURST D E et al see also Sjogren's syndrome STEVEN M M Sickle cell disease, and non-gouty arthritis, 37 consecutive LENNIE S E, STURROCK R D and GEMMELL C G En- cases 599 hanced bacterial phagocytosis by peripheral blood Silicon monocytes in rheumatoid arthritis 435 containing particles, transmission electron microscopic WESTEDT M L, EULDERINK F, HAZEVOET H M, DIJKMAN identification, in synovial fluid 624 J H and CATS A Systemic lupus erythematosus and injection, cosmetic breast augmentation, scleroderma, invasive thymoma: report of two cases 825 primary biliary cirrhosis, and Sjogren's syndrome see also ScoT-r D L et al after, possible human adjuvant disease: case STEWART J see ISENBERG D A et al report 520 STODELL M A, BUTLER R C, ZEMELMAN V A, HENRY K and SILVA M DE see DE SILVA M BREWERTON D A Increased numbers of IgG- SIN M Y see SEDGWICK A D et al containing cells in rectal lamina propria of patients SIN Y M, SEDGWICK A D, MOORE A and WILLOUGHBY with ankylosing spondylitis 172 D A Studies on the clearance of calcium pyrophos- STOKER V see LIANG M H et al phate crystals from facsimile synovium 487 STOLLAR B D see SHOENFELD Y et al see also SEDGWICK A D et al ST0RMER J see GRAN J T et al SIPE J D see BRANDWEIN S R et al STROBER S see CALIN A et al SITTON N G, TAGGART A J, DIXON J S, SURRALL K E and STROM T see EVRIN P E and STROM T BIRD H A Circadian variation in biochemical assess- Strongyloides sterocoralis, causing parasitic arthritis: case ments used to monitor rheumatoid arthritis 444 report 523 Sjogren's syndrome (sicca syndrome) STRUTHERS G R see FARR M et al autoantibodies in 243 SCOTT D L et al scleroderma, and primary biliary cirrhosis, after cos- STURROCK R see MADHOK R et al metic breast augmentation with silicone injection, STURROCK R D see BELCH J J F et al possible human adjuvant disease: case report 520 FROEBEL K et al secondary, immunohistological study 470 LEWIS D et al see also Sicca syndrome STEVEN M M et al SKINNER M see BRANDWEIN S R et al Subluxation, lateral, atlas in rheumatoid arthritis, case SKINNER R P see MADDISON P J et al report and post-mortem study: case report 341 878 Index

Sulphasalazine, in rheumatoid arthritis treatment, selective C4 deficiency, and Whipple's disease: case outcome 398 report 91 Sulphydryl (SH)-dependent lymphocyte-monocyte interac- sera, effects of immune complexes from, on human tions modulate antibody synthesis in rheumatoid monocyte locomotion and Fc receptor function 729 patients 116 P binding activity of 02-Microglobulin 267 Surfactants, identified in synovial fluid, ability to act as inhibiting natural killer cell activity, roles of disease boundary lubricants 641 activity and serum interferon 457 SURRALL K E see SITTON N G et al study of lymphocytotoxins in families of patients 136 SWANNELL A J see GRIFFITHS H T et al Systemic sclerosis (scleroderma) RUDGE S R et al antihypertensive therapy, controlled trial 407 SYMMONS D see EMERY P et al and CREST syndrome, clinical and serological SYMMONS D P M, AHERN M, BACON P A, HAWKINS C F, comparison 794 AMLOT P L, JONES E L, PRIOR P and ScoTr D L serum amyloid A protein concentration 586 Lymphoproliferative malignancy in rheumatoid prostacyclin levels, and red cell deformability 117 P arthritis: a study of 20 cases 132 SZAB6 G see LuKAcs K et al see also PRIOR P et al SZEGEDI G Y see LuKAcS K et al Synovial Tachyarrhythmia in yersinia arthritis: correspondence cells, cyclic AMP modulated by heparin 628 535 fluid, B lymphocytes, spontaneous and induced im- munoglobulin secretion, TAGGART A J, IVESON J M I and WRIGHT V Shoulder-hand rheumatoid arthritis 140 syndrome and symmetrical arthralgia in patients with Synovial fluid cells, rheumatoid arthritis, increased DNA tuboovarian carcinoma 391 and/or RNA content, flow-cytometry study 222 TAGGART A J see SIrroN N G et al complement levels, Behcet's disease: TAMPI R see THoMAS D et al correspondence 767 TAN E M see GRAu R G et al lactate levels, in septic and non-septic arthritides 742 TANAY A see CALIN A et al surfactants in, ability to act as boundary TAYLOR P C R see JONES V et al lubricants 641 Technique-related variation in results of FANA tests 755 infection, with Mycobacterium kansasii 80 TErrsSON I, WITHRINGTON R H,SEIFERT M H and VALDI- inflammation, laminin and vascular changes 109 P MARSSON H Prospective study of early rheumatoid protease/inhibitor ratios, in arthropathies, erosive and arthritis. I. Prognostic value of IgA rheumatoid nonerosive 50 factor 673 Synovitis see also WITHRINGTON R H et al in chronic sarcoidosis, non-specific histological changes Temporal arteritis, fibrin(ogen)olysis in 721 in synovium 778 Temporal artery biopsy, corticosteroid treatment 416 fibre glass induced: case report 530 TENENBAUM J see ALTMAN R D et al rheumatoid, a localised form of angioneurotic Thiomalate, free oedema? 109 P levels in rheumatoid arthritis treated with disodium Synovium, facsimile, calcium pyrophosphate crystals, aurothiomalate 698 clearance 487 in plasma and urine, sodium aurothiomalate 66 Systemic lupus erythematosus THOMAS D, GALLUS A S, BROOKS P M, TAMPI R, GEDDES R and amyloidosis: case report 649 and HILL W Thrombokinetics in patients with and anaplastic myeloma: case report 653 rheumatoid arthritis treated with D- C4 deficiency, and Whipple's disease: correspondence penicillamine 402 535 THOMAS D J B Rheumatoid arthritis and type 1 diabetes and other chronic diseases, sex hormones, men 115 P meilitus: correspondence 351 effect of high-dose methylprednisolone therapy on THOMAS D P PAGE- see PAGE-THOMAs DP phagocyte function 541 THOMAS PH, ALLAL J, BONTOUX D, Rossl F, POUPET J Y, idiotypic cross-reactions 122 P PETITALOT J P and BEcQ-GIRAuDON B Rheumatolo- and invasive thymoma, two cases 825 gical manifestations of infective endocarditis 716 with multiple microcrystal deposition disease: case THOMAS S M see BUTLER R C et al report 498 THOMPSON J M see BUTLER R C et al multiple tendon rupture, case report and review of THOMPSON M see HORDON L D et al literature: case report 347 THOMSON P J ROBERTS- see ROBERTS-THOMSON P J pericardial mesothelioma: case report 515 THOMPSON P W, KIRWAN J R and BARNES C G Practical preceded by long-term cryoglobulinaemia: case results of treatment with antirheumatoid drugs 121 P report 339 Thrombocytopenia, and chrysotherapy 113 P presence of abnormal lysosomes in lymphocytes and Thrombokinetics, in rheumatoid arthritis, D-penicillamine neutrophils during chloroquine therapy, quantitative treatment 402 ultrastructural study 710 Thrombosis, anticardiolipin antibodies, detection by new and rheumatoid arthritis and their complement binding solid phase radio-immunoassay, striking properties, characteristics of cryoglobulins 451 association 122 P Index 879

Thymoma, invasive, and systemic lupus erythematosus, VERNON-ROBERTS B Vertebral rim lesions in dorsolumbar two cases 825 spine: correspondence 662 TILIAKOS N A, RAJAPAKSE D A and WILSON C H: HLA GARRETT I R, WHITEHOUSE M W, BROOKS P M and types and palindromic rheumatism: correspondence HAYNES D R Influence of rat strain and arthritogen 538 on actions of gold drugs in adjuvant-induced TINCANI A see HULL R G et al polyarthritis 111 P Tolmetin pseudoproteinuria, obscuring gold nephropathy HAY S, CLEARLY E G, WEIBKIN 0 W, GARRETT I R, due to auranofin: case report 511 BROOKS P M and BIGNOLD L P The influence of TOOKMAN A see ISENBERG D A et al prednisolone (PRED) and methotrexate (MTX) on Total lymphoid irradiation (TLI), rheumatoid arthritis the cell and connective tissue content of sub- (RA), double-blind controlled study 121 P cutaneously implanted polyurethane sponges in TOTHILL P see REID D M et al rats 112 P Trabecular bone cells, cultured human, heparin modulates see also CLELAND L G et al response to hormones 105 P Vertebral rim lesions, dorsolumbar spine 302, Transcutaneous electrical nerve stimulation (TENS) and correspondence 662 placebo, double-blind comparison, soft tissue VON ESSEN R see SALMINEN I et al rheumatism 110 P VUENTO R, ESKOLA J, LEINo R, KoSKIMIEs S and VIANDER TRAPANI J A, WALKER I D and McKENZIE I F C Two- M IgM, IgG, and IgA synthesis in vitro in persons dimensional gel analysis demonstrates no structural suffering from yersinia arthritis and in patients with alteration of HLA-B27 polypeptides between patients ankylosing spondylitis 186 with ankylosing spondylitis and healthy individuals 177 WADDELL R W see FITZCHARLES M A et al TRIBE C R see RIDLEY M G et al WAGNER T and MOHR W Age distribution of amyloid in Triamcinolone hexacetonide and intra-articular radioac- the intervertebral discs: correspondence 663 tive yttrium, inconclusive trial 620 WAGSTAFF S see BADLEY E M et al Tubo-ovarian carcinoma, shoulder-hand syndrome and WAINWRIGHT A C see ScoTT D L et al symmetrical arthralgia in 391 WALKER I D see TRAPANI J A et al TUDOR J see BINDER A et al WALKER S H see GRAu R G et al TULLOCH J see BROUGHAM P A et al WALLINGTON T B see JONES V et al TUNCER I see AKOGLU T et al WALTON K see DYER P et al TOZWN Y see YAZIcI H et al KLIMIUK P S et al TYNDALL A DE VERE- see DE VERE-TYNDALL A WALTON K W see FARR M et al TYRRELL D A J see DE VERE-TYNDALL A et al ScoTT D L et al WASNER C see FRIES J F et al ULKU B Y see YAZICI H et al WATANABE M see NISHIKAI M et al UROWITZ M B see EHRENFELD M et al WATT I see DIEPPE P A et al WEBLEY M see HAJIROUSSOU V J and WEBLEY M VAARA P KOIVURANTA- see KOIVURANTA-VAARA P WEBSTER A D B see So A K L et al VAIDYA M C see PRAKASH S et al WEINSTEIN P S, CANOSO J J and WOHLGETHAN J R Long- VALDIMARSSON H see TEITSSON I et al term follow-up of corticosteroid injection for trauma- WITHRINGTON R H et al tic olecranon bursitis 44 VALESINI G see HULL R G et al WEISS J B see EVANS H B et al VALKENBURG H A see DE JONGH B M et al WESTEDT M L see STEVEN M M et al VALKENBURG H A see MOOLENBURGH J D et al Whipple's disease VAN DER KORST J K see MENS J and VAN DER KORST J K C4 deficiency, and SLE: correspondence 535 VAN LEEUWEN A W F M see MACFARLANE J D et al diagnosed at hip arthroplasty: case report 526 VAN ROMUNDE L K J see DE JONGH B M et al selective C4 deficiency and systemic lupus erythemato- VAN ROOD J J HLA as regulator: Heberden Oration sus: case report 91 1983 665 WHITEHOUSE M W see VERNON-ROBERTS B et al see also DE JONGH B M et al WIEBKIN 0 W see VERNON-ROBERTS B et al VAPAATALO H see KOIVURANTA-VAARA P et al WIIK A see MERETEY K et al VARGOS R BURGOS- see BURGOS-VARGOS R WILKINSON R see HORDON L D et al Vascular SELLARS L et al changes and laminin, in synovial inflammation 109 P WILLETr W see LIANG M H et al proliferation and laminin, in rheumatoid arthritis 551 WILLOUGHBY D A see SEDGWICK A D et al Vasculitic diseases, role of lymphocytes and serum SIN Y M et al factors 116 P WILSON A P R, PROUSE P J and GUMPEL J M Gold VAZQUEZ J J see PENiA J M et al nephropathy due to auranofin obscured by tolmetin VtGH E see LUKAcS K et al pseudoproteinuria: case report 511 VENGE P see HALLGREN R et al Listeria monocytogenes septic arthritis following VENNING H see HALL P J et al intra-articular yttrium-90 therapy: case report VERE-TYNDALL A DE see DE VERE-TYNDALL A 518 880 Index WILSON C H see TILIAKOS N A et al WRIGHT G see BOGHOSSIAN S H et al WILSON R E see GILMAN S G et al WRIGHT J C BUCKLAND- see BUCKLAND-WRIGHT J C WILSON T see KATZ J M et al WRIGHT V see MUNTON J S et al WINFIELD J and STAMP T C B Bone and joint symptoms in TAGGART A J et al Paget's disease 769 SHINEBAUM R et al WINYARD P, BLAKE D, RIDLEY J, BRAILSFORD S, BLANN Wrist, rheumatoid arthritis, microfocal radiographic ex- and LUNEC J Caeruloplasmin inflammatory joint amination of erosions 160 disease 108 P see also BLAKE D R et al ScoTT D G I et al YAMASHITA H see NISHIKAI M et al WISNIESKI J J Trauma and Reiter's syndrome: develop- HAMASHITA T S see KHAN M A et al ment of 'reactive arthropathy' in two patients follow- YAZIcI H, CHAMBERLAIN M A, TUZUN Y, YURDAKUL S and ing 829 MUFTrUOGLU A A comparative study of the pathergy WITHRINGTON R H, TEITSSON I, SEIFERT M H and VALDI- reaction among Turkish and British patients with MARSSON H Felty's syndrome associated with high Behget's disease 74 levels of IgA rheumatoid factor: case report 505 TUZON Y, PAZARLI H, YURDAKUL S, OZYAZGAN Y, Prospective study of early rheumatoid arthritis. OZDO0AN H, SERDAROGLU S, ERSANLI M, ULKU B Y II. Association of rheumatoid factor isotypes and MUFTUOGLU A U Influence of age of onset and with fluctuations in disease activity 679 patient's sex on the prevalence and severity of see also TEITSSON I et al manifestations of Behcet's syndrome 783 WOHLGETHAN J R see CANOSO J J et al Yersinia arthritis CANOSO J J and and ankylosing spondylitis, immunoglobulins (M, G, WOHLGETHAN J R and A) 186 WEINSTEIN P S et al demonstration of occult enteritis by "'indium leucocyte WONG K see DAVIS P et al scanning: case report 493 Woo P, COOPER C, HARRISON R, AMOS N, REEVE J and tachyarrhythmia: correspondence 535 LACHMANN P J Rheumatoid synovitis-a localised YOUNG C MACKWORTH- see MACKWORTH-YOUNG C form of angioneurotic oedema? 109 P YTrERBERG S R and SCHNITZER T J Inhibition of natural WOOD L and FERRELL W R Response of slowly adapting killer cell activity by serum from patients with articular mechanoreceptors in the cat knee joint to systemic lupus erythematosus: roles of disease activity alterations in intra-articular volume 327 and serum interferon 457 WOOD P H N see BADLEY E M et al Yttrium, radioactive, intra-articular, and triamcinolone WOOLEY P see GRIFFIN A J et al hexacetonide, inconclusive trial 620 WOOLF A see LOWFHIAN P et al Yttrium-90 therapy, intra-articular, Listeria monocy- WOOLLEY D E see BROMLEY M et al togenes septic arthritis following: case report 518 WRAIGHT P see BINDER A I et al YURDAKUL S see YAZICI H et al JONES J et al WRIGHT A, BENFIELD G F A and FELIX-DAVIES D Is- chaemic colitis and immune complexes during gold ZEIGER A R see PARK H et al therapy for rheumatoid arthritis: case report 495 ZEMELMAN V A see STODELL M A et al Annals of the Rheumatic Diseases

A journal of clinical rheumatology and connective tissue research

Editor H. L. F. Currey Associate Editors C. G. Barnes V. Wright Editorial Committee B. M. Ansell E. G. L. Bywaters A. M. Denman A. St. J. Dixon D. L. Gardner E. B. D. Hamilton T. E. Hardingham E. J. Holborow G. R. Hughes P. M. Johnson P. J. Maddison R. N. Maini A. G. Mowat R. G. G. Russell K. W. Walton J. B. Weiss P. H. N. Wood D. E. Woolley Editor British Medical Journal

Appointed by the British Medical Association and the Arthritis and Rheumatism Council for Research

VOLUME 43, 1984

LONDON BRITISH MEDICAL ASSOCIATION TAVISTOCK SQUARE LONDON WC1H 9JR